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ABSTRACT 
 
This work was designed to investigate the prevalence of avian influenza 
(AI) in Khartoum State during the period 2004 – 2007. Attempts were made 
for antibody detection and virus isolation, identification, characterization and 
determination of the pathogenicity of the isolates. Isolated viruses were 
subjected to biological and physiochemical characterization and plaque 
production in the cell culture. 
A total of 516 blood samples were collected from randomly selected 
chickens from different localities in Khartoum, Khartoum North and 
Omdurman. Two hundred and fifty four blood samples were collected during 
the period 2004-2005, while 262 blood samples were collected in 2007 after 
occurrence of the suspected outbreak of the disease. These sera were examined 
for the presence of antibodies against AI using Agar Gel immunodiffusion 
(AGID), Enzyme-Linked Immunosorbant Assay (ELISA) and 
Hemagglutination Inhibition Tests (HI). In addition, isolation and 
identification of the causative Avian Influenza Virus (AIV) was done from 50 
tissues, 100 cloacal and 100 tracheal swabs collected before and after the 
outbreak. Virus identification was done by AGID and HI. In these samples, 
AIV was also confirmed by nucleic acid amplification technique, RT-PCR.  
 xviii
The results showed that 37% and 16% of the tested sera were positive 
by ELISA for type A before and after the outbreak, respectively, 9% and 4.2% 
were positive by AGID before and after the outbreak for H5N2, respectively. 
The positive sera for AIV were further subtyped by the HI test using H5N3 and 
H7N1 antigens. The results of sera collected in 2004-2005 revealed that 60.7% 
were positive for H5N3 and 39.3% for H7N1, while   100% were positive for 
H5N3 from sera collected in 2007.  
A total of 5 virus isolates were isolated from samples in the allantoic 
fluid of 9-11-day old embryonated eggs. These isolates agglutinated chicken 
and horse RBCs and produced plaques in tissue culture, indicating that the 
virus is the highly pathogenic type. 
The biological and physiochemical properties of isolates were recorded 
for the first time for avian influenza virus in the Sudan. Generally the results 
indicated that H5 AIV is circulate in the field  of study; however N1 was not 
detected due to the lake of specific primers required for detected of that gene. 
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  ﺍﻟﻤﺴﺘﺨﻠﺹ
  
 ﻓﻰ ﺍﻟﻔﺘﺭﺓ ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡﺒ ﺍﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ ﺍﻨﺘﺸﺎﺭﻤﺩﻯ ﺼﻤﻤﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻤﻌﺭﻓﺔ 
 ﻋﺯل ﺍﻟﻔﻴﺭﻭﺱ ﻭ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻴﻪ ﻭ ﻭﻻﺠﺴﺎﻡ ﺍﻟﻤﻀﺎﺩﺓ  ﺍﻟﻜﺸﻑ ﻋﻥ ﺍ ﻤﻥ ﺨﻼل 7002-4002
  ﺍﻟﺒﻴﻭﻟﻭﺠﻴﺔ ﻭ ﻭ ﺍﻴﻀﺎ ﺩﺭﺍﺴﺔ ﺍﻟﺘﻐﻴﺭﺍﺕﺘﺠﺭﻴﺒﻴﺎﺘﺤﺩﻴﺩ ﺍﻤﺭﺍﻀﻴﺔ ﺍﻟﻌﺘﺭﺍﺕ ﺍﻟﻤﻌﺯﻭﻟﺔ 
  . ﻓﻰ ﺍﻟﺯﺭﻉ ﺍﻟﻨﺴﻴﺠﻰﺍﻟﻠﻁﻌﺎﺕﺍﻟﻔﻴﺯﻭﻜﻴﻤﻴﺎﺌﻴﺔ ﻋﻠﻰ ﺍﻟﻔﻴﺭﻭﺱ ﻤﻥ ﺤﻴﺙ ﻨﻤﻭﻩ ﻭ ﺍﻨﺘﺎﺝ 
 ﻟﺨﺭﻁﻭﻡ ﺍﺨﺘﻴﺭﺕ ﻋﺸﻭﺍﺌﻴﺎ ﻤﻥ ﻤﻨﺎﻁﻕ ﻤﺨﺘﻠﻔﺔ ﻓﻰ ﺍ ﻤﻥ ﺩﻭﺍﺠﻥﺩﻡ ﻋﻴﻨﺔ  615ﺘﻡ ﺠﻤﻊ 
 ﻭ ﺠﻤﻌﺕ 5002- 4002 ﻓﻰ ﺍﻟﻔﺘﺭﺓ   ﻋﻴﻨﺔ ﺩﻡ452  ﺠﻤﻌﺕ. ﺍﻟﺨﺭﻁﻭﻡ ﺒﺤﺭﻯ ﻭ ﺍﻤﺩﺭﻤﺎﻥﻭ
 ﺕﻓﺤﺼ. ﻓﻰ ﺍﻟﺴﻭﺩﺍﻥﺍﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ  ﻭ ﺫﻟﻙ ﻋﻘﺏ ﻅﻬﻭﺭ ﻭﺒﺎﺀ 7002 ﻋﻴﻨﺔ ﻓﻰ ﺍﻟﻌﺎﻡ 262
 ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺭﺴﻴﺏ ﻓﻰ  ﺍﻻﺠﺴﺎﻡ ﺍﻟﻤﻀﺎﺩﺓ ﻟﻠﻤﺭﺽ ﻭﺠﻭﺩ ﻠﻜﺸﻑ ﻋﻥﻋﻴﻨﺎﺕ ﺍﻟﺴﻴﺭﻡ ﻟ
ﺒﺎﻻﻀﺎﻓﺔ ﺍﻟﻰ ﻤﺤﺎﻭﻟﺔ . ﺘﺜﺒﻴﻁ ﺘﻼﺯﻥ ﻜﺭﻴﺎﺕ ﺍﻟﺩﻡ ﺍﻟﺤﻤﺭﺍﺀ ﺍﺨﺘﺒﺎﺭ ﺍﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ ﻭ ﻭﺍﻻﺠﺎﺭ
 ﻤﺴﺤﺔ 001 ﻤﺴﺤﺔ ﻤﻥ ﺍﻟﻤﺠﻤﻊ ﻭ 001،  ﻋﻴﻨﺔ ﻨﺴﻴﺞ 05ﻋﺯل ﺍﻟﻔﻴﺭﻭﺱ ﻭ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻴﻪ ﻤﻥ 
 ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺭﺴﻴﺏ ﻓﻰ  ﻭ ﺍﻤﻜﻥ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺍﻟﻔﻴﺭﻭﺱ ﺒﻭﺍﺴﻁﺔ ﻗﺒل ﻭﺒﻌﺩ ﺍﻟﻭﺒﺎﺀﻤﻥ ﺍﻟﺭﻏﺎﻤﻰ
 ﺍﻨﻔﻠﻭﻨﺯﺍ ﺍﻟﻁﻴﻭﺭ  ﻭﺠﻭﺩ ﻓﻴﺭﻭﺱﺘﻡ ﺘﺄﻜﻴﺩ. ﺀﺎﺭ ﻭ ﺍﺨﺘﺒﺎﺭ ﺘﺜﺒﻴﻁ ﺘﻼﺯﻥ ﻜﺭﻴﺎﺕ ﺍﻟﺩﻡ ﺍﻟﺤﻤﺭﺍﺠﺍﻻ
ﺍﻅﻬﺭﺕ ﺍﻟﻨﺘﺎﺌﺞ .ﺍﻟﻨﺎﺴﺦ ﺍﻟﺭﺠﻌﻰﺘﻘﻨﻴﺎﺕ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻯ ﻤﻨﻬﺎ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﺓ ﺍﻟﻤﺘﺴﻠﺴل ﺒﻭﺍﺴﻁﺔ 
 ﻗﺒل ﻭ ﺒﻌﺩ ﺍﻟﻭﺒﺎﺀ A ﻟﻠﻨﻭﻉ ﻤﻥ ﻋﻴﻨﺎﺕ ﺍﻟﺴﻴﺭﻡ ﻜﺎﻨﺕ ﻤﻭﺠﺒﺔ ﻻﺨﺘﺒﺎﺭ ﺍﻻﻟﻴﺯﺍ% 61ﻭ % 73ﺍﻥ 
ﺎﺭ ﻗﺒل ﻭ ﺒﻌﺩ ﺍﻟﻭﺒﺎﺀ ﻭ ﺠﻰ ﺍﻻﻜﺎﻨﺕ ﻤﻭﺠﺒﺔ ﻻﺨﺘﺒﺎﺭ ﺍﻟﺘﺭﺴﻴﺏ ﻓ%  2.4ﻭ % 9  ﻭﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻰ
ﻟﺘﺤﺩﻴﺩ ﺍﻟﻌﺘﺭﺍﺕ ﺒﻭﺍﺴﻁﺔ ﺍﺨﺘﺒﺎﺭ ﺘﺜﺒﻴﻁ  ﻭ ﺍﺨﺘﺒﺭﺕ ﻋﻴﻨﺎﺕ ﺍﻟﺴﻴﺭﻡ ﺍﻟﻤﻭﺠﺒﺔ  2N5Hﺫﻟﻙ ﻻﻨﺘﺠﻴﻥ 
 . 1N7H  ﻭ  3N5Hﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻻﻨﺘﺠﻴﻨﺎﺕ   ﺘﻼﺯﻥ ﻜﺭﻴﺎﺕ ﺍﻟﺩﻡ
xx 
ﻤﻭﺠﺒﺔ  % 7.06   ﺍﻥ 5002- 4002ﺍﻅﻬﺭﺕ ﻨﺘﺎﺌﺞ ﻋﻴﻨﺎﺕ ﺍﻟﺴﻴﺭﻡ ﺍﻟﺘﻰ ﺠﻤﻌﺕ ﻓﻰ
 ﻤﻥ 3N5H ﻤﻭﺠﺒﺔ ﻟﻼﻨﺘﺠﻴﻥ%001ﻭ N7H  1ﻨﺘﺠﻴﻥ ﻟﻼ3.93 %  ﻭ 3N5H ﻟﻼﻨﺘﺠﻴﻥ
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INTRODUCTION 
Poultry production is very important in Sudan as a source of dietary 
protein and as a source of income. The marketing of chickens in live bird 
markets is a common practice in many regions of the State and this presents 
particular biosecurity challenges and risks to human health. 
Respiratory diseases play an important role in poultry and result in 
substantial economic losses to the poultry industry (Glisson, 1998 and 
Villegas, 1998). 
Avian influenza (AI) is a serious viral disease of domestic poultry and 
other avian species included in OIE list A (OIE, 2006). The disease affects 
most types of birds and occurs as epidemics in poultry farms. The fatal disease 
is named “Highly Pathogenic Avian Influenza (HPAI) “. 
Highly pathogenic avian influenza strains are capable of causing severe 
economic losses including drop of egg production , mortality (as high as 
100%) of infected chicken flocks. It caused  large epidemics that devastated 
the poultry industry in many countries over the last few years. and posses 
serious risk to human health. 
The disease has worldwide distribution which varies in severity from 
mild to an acute fatal disease of chickens, turkeys and other avian species.  
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Clinically the disease is similar to infectious bronchitis, infectious 
laryngotrachitis, fowl cholera and all forms of Newcastle disease ( Jacob et al , 
1998).Since 1995 AI has became a very important disease problem throughout 
the world.Until recently, AI was not a disease commonly found in chicken 
flocks, but lately it became necessary for a large scale mobilization of federal 
and State regulatory efforts aimed at eradication. 
Recently, however, avian influenza acquired world-wide attention when 
a highly pathogenic strain of the subtype H5N1, which probably arose before 
1997 in Southern China, gained enzootic status in poultry throughout South 
East Asia and unexpectedly crossed host barriers (Perkins and Swayne, 2003) 
infecting mammals (cats, swine, humans). 
The recent outbreaks of the disease worldwide highlighted the 
difficulties in controlling this disease both in developed and in developing 
countries. Biosecurity is considered the most important tool to prevent and 
control AI.This disease may have a devastating effect on the poultry industry 
particularly following the high mortality rates in susceptible birds, but also its 
presence in a given territory results in restrictions on animal movements, 
marketing and trade of poultry products (Ilaria et al, 2002).   
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 The disease was reported in the Sudan for the first time in 1923 (Report 
of the Sudan Veterinary Service, 1923) since then, attempts were made to 
study AI in the Sudan. El Amin (2000) demonstrated antibodies to influenza 
virus in the sera of chickens and isolated influenza virus type A; this was the 
first record of isolation of influenza virus in the Sudan. Prior to that EL Amin 
and Kheir (1985) reported the presence of antibodies to influenza virus type A 
in the sera of camels, goats, sheep and cattle in Kassala area. The HPAI type A 
H5N1 was first reported in the Sudan in April 2006. 
Due to the expanding poultry production in the Sudan, the public health 
importance of the disease and scarcity of information about this serious disease 
that causes great economic losses, it was considered necessary to carry out the 
proposed research work.  
This present work was carried out to: 
 1. Determine the presence of antibodies to influenza virus before and after an 
outbreak that occurred in Khartoum State during the period 2004 to 2007. 
2. Study the clinical and pathological changes, biological and physiochemical 
characters among naturally infected chickens. 
3. Isolate, identify, characterize and determine the pathogenicity of the isolates. 
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CHAPTER ONE 
 REVIEW OF THE LITERATURE 
 
1.1 Avian influenza 
 Avian influenza (AI) is a contagious viral infection of many avian 
species worldwide including domestic poultry, wild and exotic birds, shore 
birds and migratory waterfowl. The disease prevalent is caused by the highly 
pathogenic viruses of the H5N1 subtype and is present in many countries in 
Asia, Europe, Middle East and Africa (Maria et al , 2007), The clinical forms 
vary from a very mild to a highly fatal disease. In mild infection, no symptoms 
of illness may be recognized. The disease has an incubation period of 24 hours 
to 7 days depending on the dose of the virus and route of entry (David et al , 
2003; Easterday and Beard, 1984). 
There are numerous strains or subtypes of avian influenza viruses. Most 
of these viruses are associated with subclinical or mild to moderate respiratory 
infections characterized by coughing and sneezing. Sinusitis may develop and 
infected birds often experience decreased egg production. The highly 
pathogenic forms of avian influenza (fowl plague) is presented as severe 
generalized disease with high mortality in commercial flocks. Deaths may 
occur as early as 24 - 48 hours after the onset of clinical signs. Comb and 
wattles are cyanotic and there may be an edema of the head region with 
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coughing, gasping, blood-stained oral and nasal discharges, and diarrhea 
(Carter et al , 2006). Lesions include hemorrhages and congestion of serous 
and mucous membranes, consolidation of lungs, and caseation involving the 
air sacs. Focal necrosis may be noted in the skin and internal organs. 
 Avian influenza viruses of 15 subtypes can cause low pathogenicity 
avian influenza (LPAI) in susceptible birds. This is, a mild respiratory disease 
with low mortality rates in poultry. However, in some cases, the infection  may 
cause significant mortality rates, during coinfections with other bacterial or 
viral infections. The severity of the clinical condition caused by LPAI viruses 
does not correlate with the viral subtype, as clinical conditions associated with 
decreased performances and symptoms affecting the respiratory, reproductive 
or enteric tracts have been observed with H1 (Ficken et al ., 1989), H3 (Tang 
et al ., 2005), H5 (Shortridge et al ., 1998), H6 (Webby et al ., 2002), H7 
(Capua et al ., 2000) and H9 (Nili and Asasi, 2003) viruses. 
In chickens and turkeys, morbidity and mortality rates are variable as 
the signs and depend on virus pathogenicity, host, age and environmental 
conditions (Easterday et al., 1997). 
Infection of poultry with avian influenza viruses cause a wide range of 
clinical signs including asymptomatic infections, mild to severe respiratory 
disease, production losses, and rarely, severe with high morbidity and 
mortality. 
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1.2 History of the disease 
 Avian influenza was defined as “fowl plague” in 1878 as an infectious 
disease of birds causing high mortality in chickens in Italy (Perroncito 1878). 
Due to a former hot spot in the Italian Upper Po Valley it was also referred to 
as 'Lombardian disease'. Although Centanni and Savonuzzi, in 1901, identified 
a filtrable agent as responsible for causing the disease, it was not before 1955 
when Schafer characterized these agents as influenza a viruses (Schafer, 1955). 
In the natural reservoir hosts of avian influenza viruses, wild water birds, the 
infection generally runs an entirely asymptomatic course where a virus 
biotypes of low pathogenicity co-exists (Webster et al., 1992, Alexander 
2000). 
The terminology “highly pathogenic avian influenza” was officially 
adopted in 1981 at the First International Symposium on Avian Influenza. The 
Office International des Epizooties (OIE) has included HPAI as a List A 
reportable disease (OIE, 2003). 
Since 1997, outbreaks of highly pathogenic (HP) H5N1 and circulation 
of H9N2 viruses among domestic poultry in Asia have posed a threat to public 
health (Nguyen et al., 2005). In 2003-2004 outbreaks of HPAI caused by 
H5N1 viruses were reported in eight Asian countries (Sims et al., 2005). 
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1.3 Host range 
Wild aquatic birds, notably members of the orders Anseriformes (ducks 
and geese) and Charadriiformes (gulls and shorebirds), are carriers of several 
strains of influenza virus A subtypes, and thus, most probably constitute the 
natural reservoir of all influenza A viruses (Webster 1992, Fouchier et al., 
2003; Krauss et al., 2004, Widjaja et al.  2004; Hinshaw et al., 1980; Suss et 
al ., 1994). While all bird species are thought to be susceptible to AI, some 
domestic poultry species - chickens, turkey, guinea fowl, quail and pheasants - 
are known to be highly vulnerable to the sequelae of infection. Avian influenza 
type A viruses generally do not cause disease in their natural hosts. 
(Taubenberger  et al., 2005). 
Chickens and turkeys are highly susceptible to infection and clinical 
disease. Ducks and geese are susceptible to infection with all AI virus strains, 
but only some very virulent viruses produce clinical disease. Their potential as 
reservoir hosts is considered to make waterfowl a major source of virus for 
poultry. In 2004, subtype H5N1 caused widespread deaths in ducks, geese and 
chickens in China (WHO 2004). Previously, deaths were recorded in 
waterbirds in Hong Kong in 2002. There were reports of limited mortalities in 
ducks and geese in Italy (Capua and Mutinelli 2001; Sturm-Ramirez et al., 
2004). 
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1.4 Transmission and spread of the disease 
The disease occurs in chickens, ducks, turkeys, quail, pheasants, other 
fowl and particularly in waterfowl, AI is highly contagious and spreads rapidly 
(Carter et al, 2006). 
 The virus replicates predominantly in the intestinal tract (Slemons and 
Easterday, 1975; Fouchier et al ., 2007), and is shed in faeces (Webster et al ., 
1978; Hinshaw et al ., 1980) and is subsequently transmitted and maintained 
by faecal-oral transmission. Poultry trade and mechanical movement of 
infected materials are likely modes for spreading avian influenza (Alexander, 
2000). 
Migratory birds may spread AI (H5N1) viruses to new geographic 
regions, but their importance as an ecologic reservoir is uncertain. The spread 
of influenza A (H5N1) viruses appears to be principally related to the 
movement of poultry and poultry products, ( Gauthier et al  ,2007; Kilpatrick et 
al ,2006) although recent outbreaks of virus infection in sub-Saharan 
Africa,( Ducatez et al ,2006) Egypt, and Europe may indicate introduction of 
the virus by wild birds. The risk of the introduction of influenza type A (H5N1) 
viruses into North America by birds migrating through Alaska appeared to be 
low (Winker et al , 2007). 
The risk that infection will be transmitted from wild birds to domestic 
poultry is greatest where domestic birds roam freely, share a water supply with 
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wild birds, or use a water or food supply that might become contaminated by 
droppings from infected wild bird carriers (Capua et al., 2003, Henzler et al., 
2003). 
The infection cycle among birds depends on faecal-oral transmission 
chains. Apart from being directly transmitted from host to host, indirect spread 
via virus-contaminated water and fomites is an important route in contrast to 
influenza virus infections in mammals (humans, swine, and horses) where 
transmission by aerosols prevails. 
Birds are infected by direct contact with virus-excreting animals and 
their excretions or through contact with (abiotic) vectors which are 
contaminated with virus-containing material. Once introduced into domestic 
flocks, LPAIV may be secreted to sustained horizontal transmission within and 
between flocks. HPAIV spreads by similar means. The wet markets, where live 
birds are sold under crowded conditions, are multiplicators of spread 
(Shortridge et al., 1998, Bulaga et al., 2003). 
1.5 Geographical distribution of the disease 
Highly pathogenic H5N1 influenza viruses have repeatedly caused 
serious outbreaks of disease in poultry farms since 1997 and posed  a 
significant threat to human health due to their ability to infect humans, 
resulting in high mortality (Claas et al.,1998; Subbarao et al.,1998, Peiris et al., 
2004). Since late 2003, H5N1 viruses have spread in an unprecedented manner 
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across Asia, resulting in more than 60 human fatalities in Thailand, Vietnam, 
Cambodia, and Indonesia and in the slaughter or infectious deaths of more than 
150 million birds. Despite extensive efforts to contain these outbreaks, H5N1 
viruses continue to circulate among poultry in Asia (OIE, 2008) and remain a 
threat to both veterinary and human public health.  
To date, all outbreaks of HPAI in domestic poultry have been caused by 
H5 or H7 influenza A subtypes. Until 1999, HPAI was considered relatively 
rare, with only 17 outbreaks reported worldwide between 1959 and 1998; 
however, since 1999 the number of outbreaks occurring globally has increased 
(Capua and Alexander ,2004, Capua et al., 2006). 
Nigeria was the first African country to experience outbreaks of H5N1 
in poultry (in February 2006). One study showed that three different 
sublineages were independently introduced into Nigeria through routes that 
coincide with flight paths of migratory birds, although the authors stated that 
independent trade imports could not be ruled out as the source of spread 
(Ducatez et al, 2006). Another study found that isolates from Nigeria were 
closely related to isolates from West Africa and Sudan (Fasina et al., 2008). 
1.6 Clinical features 
 Infections of domestic avian species with low pathogenic avian 
influenza (LPAI) viruses can be asymptomatic or cause a wide range of 
clinical signs varying from mild respiratory disease to more severe diseases 
 8
affecting the respiratory and enteric systems. Highly pathogenic avian 
influenza viruses (HPAI) cause rapid mortality in poultry, which often 
approaches 100% of incidence (Alexander, 2000).  
1.7 Lesions 
According to Saif (2003) the lesions of the disease are variable in their 
location and severity, depending on the host species, pathogenicity of the 
infecting virus and presence of secondary pathogens. The lesions in HPAI 
include edema, hemorrhage, and necrotic foci in liver, spleen, kidneys, 
intestine and pancreas (Easterday and Beard, 1984: Jungheer, 1946). 
1.8 Diagnosis of avian influenza 
 The recent emergence and re-emergence of influenza viruses with 
pandemic potential is of great concern to both the veterinary and public health 
communities. Early diagnosis of influenza virus infection is therefore essential. 
Clinically the disease can be confused with other poultry diseases. Thus 
definite diagnosis depends on isolation and identification of the virus (Jordan, 
1990). 
1.8.1 Isolation and Identification  
 Isolation of influenza virus was performed by inoculating 9-day-old 
embryonated chicken eggs with 0.2 ml tissue suspensions or swab suspensions 
via the allantoic cavity. The eggs were incubated for 4 days and candled daily 
for viability; embryos that died within 24 hours of inoculation were discarded 
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as nonspecific. Allantoic fluids from dead and surviving embryos were  tested 
for Hemagglutination (HA) activity. Samples that yielded no hemagglutination 
were re-inoculated for a second passage.  
OIE (2008) described the standard methods for isolation of the virus in 
chicken embryo. Also suggested the following criteria for identification of 
virus: 
- Detection of HA activity indicates a high probability of the presence 
of an influenza A virus. Fluids that give a negative reaction should be passaged 
into at least one further batch of eggs.  
- Several serological and molecular methods are available to confirm the 
presence of influenza A virus; and include:  
o Agar gel immunodiffusion (AGID) tests that demonstrate the 
presence of the nucleocapsid or matrix antigens  
o Enzyme-linked immunosorbent assays (ELISAs)  
o Reverse-transcription polymerase chain reaction (RT-PCR) using 
nucleoprotein-specific or matrix-specific conserved primers; the 
presence of subtype H5 or H7 influenza virus can be confirmed 
by using H5- or H7-specific primers  
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1.8.1.1 Hemagglutination (HA) and Hemagglutination Inhibition test (HI). 
1.8.1.1.1 Hemagglutination (HA) 
  Influenza viruses hemagglutinate avian and mammalian erythrocytes. 
The hemagglutinin (HA) protein agglutinates erythrocytes, hence the 
derivation of its name. The traditional method for identifying influenza field 
isolates takes advantage of this property (WHO, 2002). 
1.8.1.1.2 Hemagglutination Inhibition test (HI). 
 The test is a subtype specific test that measures the ability of test serum 
to block the hemagglutination of constant amount of virus (Suarez and Cherry, 
2000). 
For the avian influenza (AI) virus, the HI assay is used to identify the 
hemagglutinin (H) subtype of an unknown AI virus isolate or the HA subtype 
specificity of antibodies to AI virus. Since the HI assay is quantitative, it is 
frequently applied to evaluate the antigenic relationships between different AI 
virus isolates of the same subtype. The basis of the HI test is inhibition of 
hemagglutination with subtype-specific antibodies (Janice and Rederesen, 
2008). 
The hemagglutination inhibition (HI) assay is also a widely used 
serological method to measure the levels of protective antibody responses 
against influenza viruses. However, the traditional HI assay which uses 
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chicken erythrocytes is not sufficiently sensitive for detecting HI antibodies 
specific to avian influenza viruses. Jia et al (2008) demonstrated that 
employing an assay using horse erythrocytes increased the sensitivity of 
detecting HI antibodies specific for three major serotypes of avian influenza 
viruses. It is more sensitive than complement fixation and more specific in 
differentiating between HA subtypes (Julkunen et al , 2002) 
1.8.1.2 Agar Gel Immunodiffusion (AGID) 
The agar gel precipitation test is group-specific test and is used to 
confirm positive sera (Peter, 2006).The test is primarily used to detect group 
specific antibody, and measure antibody to both NP and M1 proteins and was 
widely used for testing chickens (Beard, 1970) and it is more sensitive than 
ELISA and HI test (Snyder et al , 1985; Meulemans et al , 1987). 
1.8.1.3 ELISA 
Enzyme-linked immunosorbent assays (ELISA) are sensitive and 
specific ELISA that demonstrates nucleoprotein of type A influenza virus 
using a monoclonal antibody against type A influenza nucleoprotein ( Slemons 
and Brugh, 1998; Swayne et al., 1998).    
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1.8.2 Molecular techniques 
1.8.2.1 Reverse transcriptase PCR (RT-PCR) 
Influenza diagnostic methods based on reverse transcription-PCR (RT-
PCR) and real-time RTPCR (RRT-PCR) are currently available for HA, but 
they are not well developed for NA identification (Poddar, 2002; Takao et al., 
2002) 
Several different methods, including traditional reverse transcription-
polymerase chain reaction (PCR), real-time reverse transcription-polymerase 
chain reaction, and nucleic acid sequence-based amplification among others, 
have been described for the diagnosis of avian influenza in poultry           
(David et al ., 2007). 
Enveloped particles of influenza A viruses harbour eight segments of 
single-stranded genomic RNA of negative polarity. Two of the eight segments 
encode the envelope glycoproteins haemagglutinin (HA) and neuraminidase 
(NA), whose antigenic properties are used to distinguish influenza virus 
subtypes ( Fouchier et al ., 2005). 
Ming et al (2001) found that RT-PCR generated results that were highly 
consistent with the serological methods; moreover, RT-PCR could be used for 
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the identification and HA-subtyping of avian influenza viruses directly from 
organ homogenates. 
RT-PCR has been used to differentiate H1 from H3 virus ( Wright et 
al ,1995 and Stockton,1998), or to differentiate N1 from N2 virus ( Stockton et 
al ., 1998). Moreover, RT-PCR followed by sequence analysis of the HA 
cleavage site was used for rapid determination of the virulence potential of H5 
and H7 viruses in birds ( Horimoto et al., 1995; Senne et al. , 1996). It is 
believed that PCR might serve as a fast and effective alternative to virus 
isolation for the detection of influenza A virus ( Claas et al ., 1993; Yuen et 
al .,1998). However, to date there is no report on differentiating H1–H15 or 
N1–N9 of avian influenza viruses by RT-PCR. 
Real-time RT-PCR (RRT-PCR) is a relatively new technology that has 
been used for avian influenza (AI) virus detection since the early 2000 for 
routine surveillance, during outbreaks, and for research. Some of the 
advantages of RRT-PCR are high sensitivity, high specificity, rapid and low 
cost. Furthermore, RT-PCR can be used with different sample types, is less 
expensive than virus isolation in chicken embryos, and since infectious virus is 
inactivated early during processing, biosafety and biosecurity are also easier to 
maintain (Eirca and David, 2008).  
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Comparative tests with throat swab samples from humans and fecal and 
cloacal swab samples from birds confirmed that the new PCR is faster and up 
to 100-fold more sensitive than classical virus isolation procedures              
(Ron et al., 2000). Spackman et al., (2002) found that the sensitivity and 
specificity of the H7- and H5-specific RRT-PCR were similar to those of virus 
isolation (VI) and hemagglutination inhibition (HI). 
Hui-Ling et al., (2006) suggested that the RT-PCR was rapid and 
specific and, therefore, could be valuable in the rapid detection of H5N1 
influenza viruses in clinics. There are many different RT-PCR methods applied 
for AIV detection (Cherian et al., 1994, Fouchier et al., 2000, Lee et al., 2001, 
Munch et al., 2001,  Starick et al .,  2000). 
Real-time RT-PCR (RRT-PCR) for type A influenza detection is widely 
used with subsequent tests for subtype identification (Spackman and Suarez 
2008). 
1.9 Avian influenza virus 
Avian influenza A viruses (AIV) are the causative agents of the 
currently most important poultry diseases. 
 The influenza A virus particle or virion is 80–120 nm in diameter and 
usually roughly spherical, although filamentous forms can occur (Jordan, 
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1990). Influenza A viruses have a segmented genome of single-stranded 
negative-sense RNA and belong to the family Orthomyxoviridae (Swayne et 
al .,  2000). The genome of influenza A virus consists of eight single-stranded, 
negative-sense genomic RNA (vRNA) segments that code for ten 10 
distinctive proteins (Sigfrido and Sergio, 2007), associated with nucleoprotein 
(NP) and the viral polymerase complex (PB1, PB2 and PA) in the form of 
ribonucleoprotein complexes (RNP) (Portela, 2002 ). The proteins can be 
divided into surface and internal proteins. The surface proteins include 
haemagglutinin (HA), neuraminidase (NA) and two matrix proteins. The HA 
and NA proteins provide the most important antigenic sites for the production 
of a protective immune response, primarily in the form of neutralizing 
antibody. There is a great deal of antigenic variation among these proteins, 
with fifteen HA and nine NA subtypes being recognized, based on 
haemagglutination-inhibition (HI) and neuraminidase-inhibition (NI) tests, 
respectively. (Swayne et al. , 2000). 
The eight gene segments of influenza A virus encode 10 proteins: 
hemagglutinin (HA), neuraminidase (NA), matrix proteins M2 and M1, 
nonstructural (NS) proteins NS1 and NS2  and the three polymerases, the PB1 
(polymerase basic 1), PB2, and PA (polymerase acidic) proteins (Webster et 
al ., 1992). 
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1.9.1 Classification 
Avian influenza viruses are classified in the family Orthomyxoviridae, 
genus Influenzavirus (Lamb and Krug, 1996; David et al , 2003, Swayne  et al , 
2003: Ito et al ., 2001). The influenza viruses of this family include three 
genera: influenza A, B and C on the basis of the antigenic character of the 
internal nucleoprotein antigen. Only influenza A viruses have been isolated 
from avian species. Influenza A viruses are further divided into subtypes 
determined by haemagglutinin (H) and neuraminidase (N) antigens. At present, 
fifteen H subtypes and nine N subtypes have been identified.Each virus has 
one HA and one NA antigen, apparently in any combination. All influenza A 
subtypes in the majority of possible combinations have been isolated from 
avian species. To date, only viruses of H5 and H7 subtype have been shown to 
cause HPAI in susceptible species, but not all H5 and H7 viruses are virulent 
(Ilaria and Alexander, 2007). 
Subtypes H5 and H7 have caused serious outbreaks of avian influenza 
in commercial flocks of chickens and turkeys (Carter et al., 2006). 
1.9.2 Pathogenicity 
 Influenza A viruses infecting poultry can be divided into two distinct 
groups on the basis of their ability to cause disease. The very virulent viruses 
cause highly pathogenic avian influenza (HPAI) that may result in mortality as 
high as 100%.These viruses have been restricted to subtypes H5 and H7, 
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although not all viruses of these subtypes cause HPAI. All other viruses cause 
a much milder disease consisting primarily of mild respiratory disease, 
depression and egg production problems in laying birds (Ilaria et al., 2002). 
 There is a wide range of pathogenicity among the avian influenza 
viruses. Infections with viruses may be inapparent or result in disease that 
ranges from mild, transient syndrome to 100% morbidity or mortality. Signs of 
the disease may be respiratory, enteric or reproductive and will vary with virus, 
species, age, intercurrent infections, environment and immune status of the 
host (Esterday and Hinshaw, 1991).. 
 Depending on pathogenicity in chickens and turkeys, avian influenza A 
viruses are classified as virulent causing fowl plague or avirulent causing mild 
or asymptomatic disease. 
 There is extreme variation in virulence among subtypes of AI viruses, 
and a variety of subtypes are widespread throughout wild aquatic bird 
populations. HPAI due to H5 and H7 subtypes can cause severe clinical 
disease, and even subtypes of low pathogenicity, including H5 and H7, can be 
associated with severe clinical disease in the presence of other infectious 
agents. The pathogenicity of AI viruses depends on the genetic properties of 
the virus and the species of the host. Only viruses with H5 and H7 antigens 
have been isolated so far from HPAI in poultry. These two subtypes of AI 
virus are considered to be high risk strains for pathogenicity drift towards 
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HPAI, even if the clinical picture seen in poultry is of lesser or no 
pathogenicity. The cleavability of viral haemagglutinins by proteolytic 
enzymes also correlates with the virulence of virus strains for chickens.LPAI 
infections of chickens and turkeys with H5 and H7 subtype that have been 
allowed to continue without adequate control or eradication procedures have 
ultimately turned into virulent HPAI infections. The change in pathogenicity of 
the virus is associated with the acquisition of additional basic amino acids at 
the cleavage site of the haemagglutinin protein. In the controlled laboratory 
environment, HPAI was generated from an LPAI H5 subtype virus, derived 
from a water bird, after 24 passages through chickens (Ito et al., 2001). 
 Most HPAI viruses isolated from poultry were from chickens and 
turkeys. Clinical signs result from the replication of the virus in the respiratory 
tract and subsequent systemic replication in the visceral organs and brain. The 
viruses that are nonpathogenic replicate only on the surfaces of the respiratory 
and intestinal tracts. The major determinant of pathogenicity of AI viruses is 
the cleavability of the H protein. If the H cleavage site has the right 
configuration of basic amino acids, the protease enzymes found in internal 
organs are able to cleave the protein. Without this configuration, however, the 
protein can only be cleaved by trypsin-like enzymes, which have a more 
restricted distribution on endodermal surfaces, such as the respiratory and 
intestinal tracts (Swayne and Suarez 2000). 
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Highly pathogenic avian influenza viruses are not necessarily virulent 
for all species of birds and the clinical severity seen in any host appears to vary 
with both bird species and virus strain (Alexander et al., 1978; Alexander         
et al., 1986) In particular, ducks rarely show clinical signs as a result of HPAI 
infections, although there are reports that some of the Asian H5N1 viruses 
have caused disease (Sturm et al., 2005). 
1.9.3 Properties of avian influenza virus 
1.9.3.1 Physical properties 
The influenza viruses are relatively unstable in the environment. Heat, 
extreme changes of pH, or nonisotonic conditions and dryness can readily 
inactivate the influenza viruses (Lamb, 1989) 
Both AI and ND viruses can cause mild to severe disease in commercial 
poultry, including egg laying chickens, with virus being shed from the 
respiratory tracts and sometimes faeces. Both viruses can be partially protected 
from heat inactivation by the presence of organic material (Alexander, 2003; 
Swayne & Halvorson, 2003). 
Orthomyxoviridae are considered to be sensitive to acid pH values, 
although their retention of infectivity is dependent on the degree of acidity that 
is obtained and the virus strain (Puri et al ., 1990). 
Influenza virus may remain infective in lake water for up to 4 days at 
22oC and over 30 days at 0oC (Webster et al ., 1978). 
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Data have demonstrated that an AIV H7N3 subtype at a concentration 
of 4 HA units in peptone water (pH 7.0) decreased its HA activity but 
preserved its infectivity when incubated at 4, 30 and 37°C for 35 days 
(Muhammad et al ., 2001). Infectivity of the same strain was also retained 
following exposure to higher temperatures, such as 56°C for 30 min but was 
lost after a prolonged exposure at 56°C for 60 min (Muhammad et al ., 2001). 
These data were ingreement with the studies on the resistance of four LPAI 
strains H7N2 subtype (Castro et al ., 1998; Lu et al ., 2003). The viruses, from 
104 to 105 ELD50/ml, retained their infectivity after 30 min at 56°C in a water 
bath and were completely inactivated after 60 min at the same temperature or 
after 10 min at 60°C (Castro et al ., 1998; Lu et al ., 2003). 
King (1991) also evaluated the heat inactivation of AIVs at 56 and 
60°C. Two LPAI strains (H5N9) and (H9N2) were selected to investigate the 
heat stability at 56 and 60°C. Both viruses were completely inactivated after 
60 min at 56°C and after 30 min at 60°C. 
 Also inactivation of the virus occurred at temperature of 560C for 30 hr 
and 600C or more for 30minutes (OIE, 2002).   
Lu et al  (2003) studied the infictivity and inactivation of the H7N2 AIV 
in various environmental conditions, heat,pH and disinfectants, they found that 
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the virus was effectively inactivated at pH 2, heating at 560C and exposure to 
70% ethanol in less than 30 min. Songserm et al., (2006) studied the stability 
of H5N1 HPAI virus isolated in Thailand determining the survival of the 
infectious virus (initial dose of 106.3 ELD50/ml) mixed with chicken faeces 
under different environmental conditions. They concluded that virus was 
completely inactivated within 30 min after direct sunlight exposure.It can also 
be inactivated by heating to 56°C (133°F) for a minimum of 60 minutes 
(Center, 2007). 
1.9.3.2 Chemical properties 
The influenza viruses are relatively unstable in the environment. Heat, 
extreme changes of pH, or nonisotonic conditions and dryness can readily 
inactivate the influenza viruses. 
1.9.3.3 Biological properties 
 The surface glycoproteins HA and NA are critical for the biology of 
influenza virus. HA is responsible for the virus attachment to the cell surface, 
binding to sialic acid residues in cell membrane glycoproteins, thus triggering 
viral fusion and entry (Takeda et al., 2003). Some HA types can be cleaved by 
different proteases, what enables the virus to spread more efficiently in vivo 
(Gamblin et al., 2004; Steinhauer, 1999). The antigenic diversity of HA and 
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NA provides for Influenza A virus subtyping. Fifteen HA and nine NA 
subtypes are currently recognized (Jose et al., 2007). 
1.9.3.4 Plagues formation on cell culture 
Plaque assay in cell culture monolayer are the most common method for 
quantification of infectious viruses. In these assays, each infectious virus 
particle multiplies under conditions that results in localized areas of infected 
cells known as plaques (Mikhail et al., 2006). 
Avian influenza viruses replicate in a limited number of cell cultures; 
Chicken Embryo fibroblast (CEF) are the most commonly used primary 
cultures whereas the most frequently used continuous cell line is the MDCK. 
 Few influenza viruses will not grow and produce plaques in cell culture 
unless trypsin is added to the agar overlay to cleave the HA molecule for 
production of infectious virus. Using trypsin in the culture medium allows 
plaques assays with many strains in CEF or MDCK (Calnek et al , 1995). 
Several plaque tests for influenza viruses have been described (Granoff, 
1955; Ledinko, 1955; Gotlieb and Hirst, 1956; Henry and Youngner, 1957; 
Wright and Sagik, 1958; Choppin,1962; Lehmann - Grube, 1963). 
All influenza strains tested were propagated in chick embryos and 
formed plaques regularly. 
 Since all influenza virus strain tested formed plaques in primary Chick 
Kidney Cell (CKC) this system is especially suitable not only for infectivity 
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test, but also for genetic studies (Babiker and Rott,1968). A wide variety of 
influenza A viruses comprising human, equine and avian strains grow 
productively in an established lines of Canine Kidney cells (MDCK) under an 
overlay medium containing trypsin and formed well defined plaques     
( Tobital et al.,  1975). 
Several strains of influenza virus studied for their ability to form 
plaques in monolayer tissue culture of CEF from 9-11 day old produced 
plaques in this culture by 4 days (Granoff, 1955). 
1.9.3.5 Replication and pathogenesis of the H5N1 virus 
 In vivo the H5N1 virus enters the host’s body either through the 
respiratory tract or the gastrointestinal tract. In the first instance the host cell 
would be a cell in the respiratory tract, in the lungs or in the gastrointestinal 
tract. However the virus can cause systemic dissemination therefore, 
subsequently, the host cell could be one of many organs, such as the pancreas, 
kidneys, heart or brain. During the adsorption phase,  the HA binds to the 
host’s sialic acid which is a sugar found on cell surface proteins. The HA has 
mutated which allows it to bind to the different types of sialic acid which occur 
in humans and birds (Mackenzie, 2006). The cell then engulfs the virion, 
simultaneously trapping the protease with the virion which attacks the HA. The 
virus has evolved so that instead of harming the HA, the protease removes a 
type of ‘safety catch’ which activates the HA due to post-translational cleavage 
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of the precursor form of the virus, HA0, by the protease (Alexander et al., 
2004; Mackenzie, 2006). For low virulence influenza viruses, the HA could 
only become functional and infectious by being cleaved by proteases found at 
certain sites, such as trypsin or similar enzymes, which restricted the site of 
replication of the virus to, for example, the respiratory or digestive tracts. In 
contrast, HA of highly pathogenic avian influenza (HPAI), can be cleaved by 
other proteases, such as furin (Stieneke-Grober et al ., 1992), which allows the 
virus to replicate in other parts of the body. This damages vital tissues and 
organs, causing mortality, which may be as high as 100% (Alexander et al ., 
2004). It has been found that avian influenza viruses with low virulence have 
one basic amino acid, arginine, at the HA0 cleavage site whilst HPAI viruses 
have many basic amino acids, arginine and lysine, next to the cleavage site 
which can be cleaved by ubiquitous proteases (Senne et al., 1996). The host 
cell pumps in acid to kill the virion however the acid enters through the M2 ion 
channel triggering a change in the activated HAs. The globular head of the HA 
folds back and the inside sections bind to the cell membrane (Mackenzie, 
2006). This fusion causes the virus capsid to break open and a pore forms 
between the cell membranes. The RNAs leave the virion during this uncoating 
process and migrate into the cell’s nucleus (Mackenzie, 2006). Polymerase 
enzymes which were packaged with the RNAs produce messenger RNA 
(mRNA) copies of viral genes. The host cell then produces thousands of 
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replications of the ten proteins that were coded for by the viral genome and 
then copies of viral RNA (Mackenzie, 2006). The new viral surface  proteins, 
HA, NA and the M2 channel, migrate to the cell membrane where the NA 
destroys any protruding sialic acid which means that the new viral components 
float to new cells (Mackenzie, 2006). The M1 matrix protein helps to 
compartmentalise new virions by packing the new viral genome together into 
cell membranes to join viral surface proteins (Mackenzie, 2006). H5N1 viral 
replication has been found to be prolonged in human patients with 
nasopharyngeal isolates being found from a range of 1 to 16 days (median 6.5 
days) in 1997 viruses and the onset of illness to first culture ranging from 3 to 
16 days (Writing Committee of World Health Organization(WHO,2005). The 
high frequency of diarrhoea in patients and the detection of viral RNA in faecal 
samples suggest that viral replication occurs in the gastrointestinal tract (De 
Jong et al ., 2005). This was confirmed by one autopsy (Uiprasertkul et al ., 
2005). 
In vitro influenza virus attachment to the susceptible cell is mediated by 
the interaction between the viral hemagglutinin and sialic acid receptors 
present on glycolipids and glycoproteins on the cell surface (Lamb, 1989). At 
this stage, the sialidase activity of the neuraminidase prevents binding of the 
HA to sialic acids present in mucopolysaccharadies, which would otherwise 
interfere with the virus binding to the adequate cellular receptors. The virus is 
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internalized by endocytosis and, upon acidification of the endosome, 
conformational changes on the hemagglutinin lead to the fusion between the 
viral and the endosomal membranes (Lamb, 1989). Acidification of the 
endosomal lumen also activates the ion channel activity of the viral membrane 
protein M2 (Pinto et al ., 1992). Activation of M2 generates an inward current 
of protons into the virion’s interior that triggers the disassembly of M1 from 
the vRNPs, which are transported to the nucleus, the site of influenza virus 
transcription and replication (Martin and Helenius, 1991). A minimal set of 
four viral proteins is essential for influenza virus transcription and replication: 
PB1, PB2, PA - referred to as P-proteins-, and the NP protein (Huang, Palese, 
and Krystal, 1990). Two different populations of positive sense RNAs are 
synthesized from vRNA templates: messenger RNAs (mRNAs) and 
complementary RNAs (cRNAs). Viral mRNAs are primed by 5’ capped 
(m7GpppNm-containing) fragments derived from newly synthesized host-cell 
RNA polymerase II transcripts (Beaton and Krug, 1986; Krug et al ., 1989; 
Plotch et al ., 1981; Ulmanen et al., 1983)Viral mRNAs are polyadenylated by 
a stuttering mechanism involving the viral polymerase and a stretch of 
uridines, which are located 17-22 nucleotides before the 5’ end of the vRNAs 
(Hay et al ., 1977; Robertson et al ., 1981); Synthesis of cRNA is the first step 
in influenza virus replication. Transcription of cRNAs occurs in the absence of 
primer or polyadenylation and they represent full-length copies of vRNAs 
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(McGeoch et al ., 1976). The second step in viral replication is the synthesis of 
progeny vRNA molecules from cRNAs templates (McGeoch et al ., 1976). 
Towards the end of the infection cycle and once enough molecules of M1 and 
NP have been produced, the newly synthesized vRNPs are exported out of the 
nucleus and assembled into full virus particles. The final assembly steps occur 
at the plasma membrane exposing the newly synthesized hemagglutinin, 
neuraminidase proteins, and M2 (Helenius, 1992.) Once the final assembly 
events are completed, new virus particles bud from the plasma membrane. The 
activity of the neuraminidase becomes again important by disrupting viral 
aggregates and thus releasing viral particles that can start a new cycle of 
infection. 
1.10 Prevention and control of the disease  
 In the face of disease outbreaks in poultry and the potential pandemic 
threat to humans caused by the highly pathogenic avian influenza viruses 
(HPAIVs) of H5N1 subtype, improvement in biosecurity and the use of 
inactivated vaccines are two main options for the control of this 
disease.( Huoying et al. ,2007).  
Recent outbreaks of highly pathogenic avian influenza (HPAI) viruses 
in poultry and their threatening zoonotic consequences emphasize the need for 
effective control measures. (Van der et al., 2005)  
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Although culling of infected poultry remains the most effective strategy 
to prevent the transmission of the avian influenza virus, when the viruses are 
widely spread in multiple domestic and wild avian species such as in the case 
of the Asian H5N1 epidemic, "stamping out" alone is unlikely to be successful. 
Depopulation of infected flocks in combination with vaccination of at-risk 
poultry populations is being implemented in several Asian countries, Italy, and 
Mexico as an alternative strategy to control the spread of the disease (Capua   
and Alexander, 2004; Lee et al, 2004; Marangon and Capua, 
2006).Vaccination of high-risk birds or flocks has been shown to be an 
effective complementary tool to control the spread of avian influenza (Ellis et 
al , 2004) 
1.10.1 Vaccination 
 When an outbreak of AI occurs in an area with a high population 
density in which the application of rigorous biosecurity measures is 
incompatible with the modern rearing systems, vaccination should be 
considered as a first option to control the spread of infection. 
 Inactivated vaccines against influenza in birds were used in some 
outbreaks (Beard, 1991). Vaccination has been prohibited in outbreaks 
involving highly pathogenic viruses, when eradication is the goal. 
 The use of genetic engineering has been applied to isolate the 
haemagglutinin genes, particularly H5 and H7, and place them into alternate 
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viral vector such as vaccinia virus (Chambers, 1988).These have been used 
successfully to immunize and protect birds . Swayne et al(2000) suggested that 
vaccination has the potential to reduce environmental contamination with avian 
influenza virus and prevent subsequent bird-to-bird transmission. 
In order to prevent spread of influenza viruses, emphasis must be placed 
on biosecurity and flock management practices, the development of rapid 
diagnostics (Lau et al , 2004) and vaccine production (Lipatov et al , 2004). 
The vaccination program is a reliable strategy in controlling the disease (Ming 
et al , 2006) 
 Current influenza vaccines include a subunit vaccine (Babai et al , 
1999; Laver and Webster , 1976], attenuated vaccine (Horimoto et al , 2004; 
Liu et al , 2003), DNA vaccine (Watabe et al , 2001) and inactivated influenza 
vaccine (Cao et al , 1992), with the latter being the most widely used on a 
commercial scale (Lipatov et al. , 2004). Vaccination with a commercial H5N2 
vaccine proved immunogenic throughout the range of species tested, with 
some variations between and within taxonomic orders (Joost et al , 2007). 
Vaccination was planned to be used on a nation wide scale in several countries 
in South East Asia (Normile 2005). 
Halvorson (2002) argued that the use of vaccines to control H5 and H7 
LPAI infections in commercial poultry decreases the risk of HPAI occurring, 
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decreases susceptibility to AI infection, decreases the quantity of virus 
produced, lessens transmission and markedly reduces economic losses. He 
concluded that there is no justification for not permitting the use of inactivated 
vaccine to control LPAI (H5/H7) in the absence of HPAI. 
Recently vaccines have been developed employing new technologies 
such as baculovirus derived H5 and H7 haemagglutinins (Crawford et al ., 
1999) and fowl poxvirus recombinants expressing H7 haemagglutinin (Boyle 
et al ., 2000). 
An inactivated H5N2 vaccine was used in Mexico as a result of the 
widespread HPAI outbreaks caused by H5N2 virus that began in December 
1994 (Villareal and Flores 1997). Between the beginning of 1995 and May 
1997 847 million doses of vaccine were licensed for use. Inactivated H7N3 
vaccine was used extensively in Pakistan following the widespread HPAI 
outbreaks in 1995 (Naeem, 1998). 
Trevor et al , 2004 found that use of killed H5N2 vaccine in the face of 
HPAI H5N1 virus challenge was able to protect chicken from disease and 
interrupt virus transmission. 
1.10.2 Detergents and disinfectants 
Influenza viruses are killed by most detergents and disinfectants. 
Organic material has a negative effect on the efficacy of a disinfectant; viruses 
which are covered with manure are well protected and can survive up to 
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approx. 100 days. Complete removal of organic material is therefore an 
essential part of an effective disinfection procedure (http://www.avian 
influenza-disinfectant.com/). 
Disinfectants active against AIVs can be grouped into soaps and 
detergents like, alkalis, acids, chlorine and chlorine compounds, oxidizing 
agents, aldehydes, phenol compounds, quaternary ammonium compounds 
(QACs) and alcohols (Maris, 1995; Ausvetplan, 2005). 
The influenza viruses are susceptible to a variety of disinfectants 
including sodium hypochlorite, 70% ethanol, oxidizing agents, quaternary 
ammonium compounds, aldehydes (formalin, glutaraldehyde, formaldehyde), 
phenols, acids, povidone-iodine and lipid solvents(Center,2007). 
phenolic disinfectants, a quaternary ammonia compound a peroxygen 
compound,Virkon-S and sodium hypochlorite (household bleach). All five 
disinfectants were effective at inactivating AIV at the recommended 
concentrations (Suarez et al., 2003) 
1.11 Avian influenza in Sudan  
The disease was reported in the Sudan for the first time in 1923 ( Report 
of the Sudan Veterinary Service, 1923) Since then Elmubark (1970) reported 
that he was unable to isolate the virus of fowl plague. Then Elamin and Khier 
(1985) using the AGID to detected antibodies to influenza virus in large animal 
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sera in Kassala region, they reported that positive reaction for influenza virus 
type A were obtained in two (4.7%) of 42 camel sera, four (5.4%) of 74 goat 
sera, six (7.2%) of 86 sheep sera, two (2.9%) of 70 cattle sera and no 
antibodies were detected in donkey sera. 
The first report of isolation of avian influenza virus was done by Elamin 
(2000) from outbreaks in poultry farm in 1998 in Khartoum State; she was able 
to obtain 31 isolates from 97 samples. 
In 2006 Eltahir found that 24% out of 100 human sera and 32% out of 
100 chicken sera were positive by using AGID. Saeed (2006) used the 
hemaggltination inhibition test against H7 and H5 antigens for sera collected 
from 100 chicken and 100 human, the results show that 21 out of 100 collected 
from chicken were positive with antibodies against H7 antigens, and two were 
positive against H5 antigens, also 15 sera were positive out of 100 collected 
from human. 
AI H5N1 was reported in Sudan for the first time in April 2006 in two 
poultry farms in Khartoum and Aljazeera State (OIE, 2006). 
Wegdan and Kheir (2007) were able to isolate a HPAI H5N1 from 
outbreak which occurred in six farms in Khartoum and two farms from 
AlGazeera States in 2006.  
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1.12Avian influenza in humans 
Avian influenza viruses also pose a significant threat to human health as 
these viruses have been shown to be able to infect humans. AI virus infection 
is not usually considered a zoonotic infection, but under certain circumstances, 
the virus poses a serious public health threat (Chang et al., 2005). The two 
subtypes, namely H5 and H9, that are currently endemic in poultry in some 
regions of the world, have been shown to be capable infecting humans 
(Subbarao et al ., 1998; Bridges et al ., 2002) and there have been several 
reports of H7 viruses infecting humans, including those isolated during the 
recent HPAI outbreaks in the Netherlands and Canada (Alexander, 2006). 
In 1996 an H7N7 virus was isolated in England from the eye of a 
woman with conjunctivitis who kept ducks. This virus was shown to be 
genetically closest in all eight genes to viruses of avian origin and nucleotide 
homology in the HA gene with a virus of H7N7 subtype isolated from turkeys 
in Ireland in 1995 (Kurtz et al ., 1996). 
In May 1997, a highly virulent strain of influenza A (H5N1) virus 
entered the human population, causing a fatal illness in a 3-year-old boy living 
in Hong Kong (De Jong et al , 1997). This strain of influenza virus received 
worldwide attention when 17 additional cases with 5 deaths were described 
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during the following winter. This virus has features common to other highly 
pathogenic avian viruses, including a series of basic amino acids adjacent to the 
cleavage site of the hemagglutinin (HA) (Subbarao et al , 1998; Claas et al , 
1998). 
There was some evidence of very limited human to human spread of 
this virus, but clearly the efficiency of transmission was extremely low 
( Buxton Bridges et al ., 2000). There have been no new cases since December 
1997. The viruses isolated from the human cases appeared to be identical to 
viruses first isolated from chickens in Hong Kong in March 1997 following an 
outbreak of highly pathogenic disease. Both human and avian isolates possess 
multiple basic amino acids at the HA0 cleavage site.  
 It has been suggested that a pandemic of influenza could begin with an 
isolated case of an avian or swine influenza virus strain crossing the species 
barrier and adapting to the human host, preceding rapid spread of the virus 
(Webster et al, 1997). 
The first outbreak of human cases of avian influenza was reported in 
1997 in Hong Kong. Since 2003, there have been many small outbreaks of 
human cases around the world, and the reported mortality is greater than 50%. 
Current evidence suggests that the human-to-human transmission of avian 
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influenza is rather inefficient, but mutation might occur in the future resulting 
in improved transmission and possibly a pandemic in human (Wong and 
Leung , 2007). 
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CِHAPTER TWO 
MATERIALS AND METHODS 
2.1. Study area   
The study was conducted in Khartoum State because it has the largest 
chicken population in the country.  
2.2. Samples 
Seven hundred and sixty six samples consisting of 200 tracheal, cloacal 
swabs, 50 tissues (lung, trachea, liver, spleen and intestine content) and 516 
serum samples were collected from White Bovan chickens in different farms in 
Khartoum area (Table 1).   
2.2.1. Collection of samples   
 2.2.1.1 Swabs and tissues  
  Tracheal and cloacal swabs were collected from dead and live chickens 
by using absorbent cotton swabs, labeled and replaced in containers. Samples 
from lungs, spleen, liver, trachea and heart were also collected aseptically by 
sterile scissors and forceps, placed into sterile bottles containing Phosphate 
Buffer Saline (PBS) with 5% antibiotics (Penicillin, Streptomycin, Gentamycin, 
and Mycostatin) and labeled. All samples were transported to the laboratory on 
ice and then stored at - 40ºC until used.   
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         Table 1: Geographical sites where the samples were collected 
              
Samples  
T C.S T.S
 Chicken age 
in weeks 
Population
Of chicken 
Farms
- 30 30 48  3000 Shambat  
 
30 20 20 8  2000 Alhalfaia
20 20 20 8  2000 Algirif 
West 
- 10 - 18  10000 Alfaki 
hashem
- 20 30 12  2000 Alftahab
 
  
T.S = Tracheal Swab.  
C.S = Cloacal Swab.   
            T   = Tissue (trachea, lung, liver, spleen and heart)   
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2.2.1.2. Serum samples.  
The blood was collected from chickens in commercial farms and 
government farms in Khartoum State. 
 Blood samples were taken from the wing and right jugular vein into 
sterile Bijou bottles and were left to clot at room temperature. The clot was 
separated from the edges of the bottles and left overnight at 4 ºC. Sera were 
taken then collected and stored at -20 ºC until used  
2.3. Embryonated hen's eggs   
One day old fertile eggs were obtained from a flock of White Bovan 
chickens in the department of Preventive Medicine, Faculty of Veterinary 
Medicine and from Koral commercial poultry farm, Khartoum. The eggs were 
incubated at 37 ºC in an egg incubator and were turned daily for ten days and 
used as eleven day- old embryo.  Embryonated eggs were also obtained from 
CVRL farm, Soba at 9-10 days of age.  
2.4 Sterilization  
2.4.1. Glassware and instruments. 
Glassware like beakers, flasks, pipettes, centrifuged tube,   bottles, 
measuring cylinder were rinsed in tap water and all solid matter washed away. 
They were then immersed overnight in 1% NaOH  , after which they were 
immersed in 1% Hcl for two hours the following day and then boiled in water 
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with detergent for 20 minutes and rinsed in running tap water for five times to 
remove detergent completely. After that they were rinsed in 5 changes of 
distilled water, left to dry and finally sterilized in the oven at 1800C for 2 hours. 
Scalpels, scissors, forceps, pestle and mortar were sterilized in the hot air oven 
at 160 ºC for 2 hours. 
2.4.2 Sterilization of microtiter plates 
 When live virus was used the plates were shaken in a solution of 1% 
NaoH till the red cells were loosened and removed, they were then soaked in 
the same solution overnight, and in the following day they were rinsed in tap 
water and soaked in hydrochloric acid solution for two hours. They were then 
rinsed in four changes of deionized distilled water (DDW) and left to dry at 
room temperature.                       
2.4.3 Solutions and plastic ware. 
Saline, buffer Solutions, sand, measuring cylinder and bottles with 
rubber caps were autoclaved at 121 ºC for 15 minutes. 
2.5 Avian influenza antisera. 
Positive sera for H5N3 and H7N1 were obtained from Central 
Veterinary laboratory, Soba. 
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2.6 Avian influenza antigens. 
Reference strains H5N3, H7N1 for hemagglutination inhibition test and 
H5N2 for Agar Gel Immunodiffusion Test were obtained from Central 
Veterinary laboratory, Soba.. Inactivated reference H5N1 type antigen was 
obtained from a commercial source in Khartoum. 
AI antigen for agar gel Immunodiffusion test (AGID) was also prepared 
in eleven-day-old chorioallantoic membrane (CAM) of 11-day-old chick 
embryos from field isolates. 
2.7 Isolation of virus  
2.7.1. Preparation of inoculum 
Swabs were rotated for one minute and the fluids were then centrifuged 
at 1000 r p m for 5 minutes. The supernatant was collected in sterile containers 
and stored at -40 ºC until used. 
In case of tissues (lung , liver , spleen , heart ) , 10% suspensions in 
PBS were prepared by pooling half gram of each tissue and mincing with 
sterile scissor and grinding with sterile mortar and pestle using sterile sand. 
The mixture was then added to 10 ml PBS containing antibiotics .Then the 
latter was centrifuged at 1000rp m for 5 minutes. The supernatant was 
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carefully removed and stored at – 40ºC until used for egg inoculation (OIE 
Manual, 1996). 
  The supernatant was then aseptically removed and placed in vials for 
egg inoculation and storage. Specimens were kept at room temperature with 
antibiotics for 1- 2 hr before inoculation into eggs to reduce bacterial 
contamination. 
2.7.2. Egg inoculation   
Five 9-11- day – old embryonated chicken eggs were used for each 
sample and other five embryonated eggs were kept as un inoculated control.  
 Before inoculation all embryos were candled for viability, and the site 
of inoculation was marked which must be free of large blood vessels, and 
disinfected with 70 % alcohol. A hole was then made in the labeled area 
between the air sac and the CAM by blunt needle. O.2 ml of the inoculum per 
egg was introduced into the allantoic cavity by inserting the needle 5/8 inch 
vertically through the hole away from the center of the egg. The inoculated 
eggs were rocked gently to ensure even distribution of the inoculum. Then the 
hole was sealed with wax and the inoculated eggs were incubated in a 
humidified atmosphere at 37ºC without turning for four to seven days. 
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2.7.3. Examination of inoculated eggs. 
 Inoculated eggs were candled once a day and embryos that died within 
24 hours were discarded as non specific deaths due to injury or bacterial 
contamination. All embryo deaths beyond 24 hr were attributed to the growth 
of the virus. The dead and live inoculated eggs were refrigerated for at least 
four hours at 4°C before harvesting. 
2.7.4. Harvesting and preservation of allantoic and amniotic fluids and 
CAM. 
  The shell over the air sac was disinfected with 70% alcohol and 
cracked by tapping with the blunt end of sterile forceps. The CAM, and the 
amniotic membrane were gently ruptured using sterile forceps ,the fluids were 
aspirated with a sterile syringe and clarified by centrifugation at 1000 r p m for 
10 minutes and the supernatant was placed into sterile eppendorf tubes and 
kept at – 20ºC until used .  
The CAM was collected after discarding the contents of the eggs with 
sterile forceps and placed in a Petri dish containing sterile normal saline. It was 
examined for virus growth, thickening of CAM and hemorrhage, then collected 
in sterile containers and kept at -20 ºC.          
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2.7.5. Passage of isolates. 
The harvested fluid was centrifuged at 1000rp m for 5 minutes. 0.2 ml 
of the supernatant containing 5 % antibiotics was inoculated into the allantoic 
sac of 10-day old embryonated eggs.  
2.8 Identification of virus. 
This was based on: 
2.8.1. Death of embryos. 
 Inoculated eggs were examined by candling to detect embryos 
mortality. Embryos usually died 36 to 96 hours after inoculation. 
2.8.2. Hemagglutination test for chicken RBCs . 
2.8.2.1. Preparation of 1% chicken RBCs . 
This was done according to OIE manual,1996 
2.8.3 Hemagglutination test (HA). 
 This test was carried out as described by (OIE Terrestrial Manual, 
2008). 
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2.8.4 Hemagglutination inhibition test (HI) 
This test was performed as described by (OIE Manual, 1996). 
2.8.5 Agar gel precipitation test (AGPT) for antigens. 
2.8.5.1 Preparation of antigen. 
 Allantoic fluid from passage two of the field isolates were inoculated in 
amount of 0.2 ml in embryonated eggs. Five eggs were used for each isolate. 
 The five isolates were A-1, A-11, A-45, C-1 and C-45.The CAM and 
the allantoic and amniotic fluids were collected under aseptic conditions and 
kept frozen at -20 0C until used in HA. The CAM antigen was ground in 5 ml 
PBS containing 5% antibiotics in a mortar, then homogenized in a 
homogenizer and kept at -40ºC.The antigen was frozen and thawed three times 
before being used in AGID.  
2.8.5.2 Preparation of agar gel  
This was prepared by dissolving one gram of agarose in 100 ml of 
normal saline 0,85%.0.5 mg of sodium azide was added to all agar preparations 
as a preservative. The agar was boiled for 45-60 minutes it was then distributed 
in 0.5 ml amount in Petri dishes, placed on the bench at room temperature to 
solidify and then kept at 4ºC. 
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2.8.5.3 Testing and examining of agar plates  
 A rosette of six peripheral wells and a central well were cut with a 
template. The plugs were carefully removed with a needle. Each peripheral 
well was filled with 25 microliter of antigen using microliter pipette while the 
central well was filled with 25 microliter of reference antisera. The plates were 
incubated in a humid chamber for ten days at room temperature and were 
examined daily in a dark room through transmitted light for precipitation bands. 
2.9  Virus isolation and plaque production in cell culture 
2.9.1. Chick embryo fibroblast  monolayer  culture (CEF).    
A group of 9-10 day-old embryonated eggs were used after being 
candled to check for viability. The blunt end of the eggs was sterilized by 
swabbing with 70% alcohol. The shell over the air sac and the membrane were 
peeled off and the CAM was broken. The embryos were hooked around the 
neck and transferred to a Petri dish containing 10 ml of cold PD. The embryos 
were then drained and transferred to a dry Petri dish .The head, viscera and 
limbs were discarded. The bodies were minced with a pair of sterile scissors. 
The minced bodies were transferred to a trypsinization flask and washed twice 
with PD solution by gentle stirring with magnetic stirrer for one minute. 
Trypsinization was carried out each time for one minute. The digested cells 
were poured into a flask on ice containing 1-5 ml calf serum to stop the action 
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of the remaining trypsin. Then the cells suspension was filtered through a 
muzlin gauze and centrifuged for 10 minutes at 1000 rpm in refrigerated 
centrifuge. The cell pellet was broken up by gentle repeated pippetting in 10 
ml of growth medium to break up cell clumps. The resultant cells were 
resuspended in 100 ml of growth medium after measuring the PCV.  
2.9. 2 Chick Kidney Cell Culture (CKC). 
5-6 day-old healthy chicks were used. The chicks were scarified and 
dipped in 70% alcohol. The abdomen was opened and the kidneys were 
displayed. They were aseptically removed and washed in PD three times. The 
fibrous tissue was picked out and the kidneys were chopped with a pair of 
scissors and washed once more in PD solution. The tissue fragments were 
trypsinized repeatedly using 0.25% trypsin solution in PD at intervals of 10 
minutes until they were completely digested. The suspension was then passed 
through a muzlin funnel and washed three times by centrifugation at the rate of 
1500 rpm for 10 minutes. They were finally suspended in outgrowth medium 
and dispensed in small flasks. 
2.9.3  Inoculation of the virus isolates in CEF monolayer and CKC 
 The established monolayer should be confluent and non should show 
vaculation. The growth medium was decanted and the sheets were washed 
twice with sterile PBS. Serial 10-fold virus isolate dilutions from 10-5 -10-10 
were each inoculated in a pair of dishes at the rate of 0.2 ml per well of tissue 
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culture plate and flask and incubated at 37°C for 30-45 minutes for plaque 
production. During this time the first overlay medium mixture was prepared 
and incubated at 42°C. 
2.9.4  Cytopathic effect of  the  isolates 
For demonstration of cytopathic effect (CPE), CEF and CKC monolayer 
were prepared in 25 ml plastic cell culture flasks that had cover slips put 
inside. The growth medium was discarded and all flasks were washed with 
sterile PBS. 1 ml volume of 10-5 dilution of the isolate was inoculated in two 
flasks. All flasks were incubated for 45 minutes at 37°C for virus adsorption, 
then 10 ml of outgrowth medium was added to each flask and all were 
incubated for 24 hours at 37°C and the presence of CPE was observed daily. 
2.9.5 Addition of overlay medium  
The overlay medium was added in the rate of 3 ml/plate per  well and 
left for 10-15 minutes to harden and was then transferred to CO2 incubator, 
preferably after sealing, incubated at 37°C for 4 days during which the plates 
were observed daily for presence of plaques ( Appendix IV). 
2.10 Serological methods  
2.10.1 Chicken sera for serological tests  
These bloods were collected from different farms in Khartoum State. 
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2.10.2  Hemagglutination test (HA) for chicken RBCs 
2.10.2.1 Preparation of 1% chicken RBCs. 
An equal volume of Alsever’s solution and chicken blood obtained from 
the wing vein of disease controlled chickens, were collected in sterile syringes, 
mixed gently and transferred slowly to a large centrifuge tube for washing. An 
equal amount of  PBS at pH 7.2-7.4 was added and the suspension was 
centrifuged at 500 r p m for 5 minutes , the supernatant was poured off , and 20 
volumes of PBS was added to the packed cells , the centrifugation step was 
repeated three times . The cells were then used to prepare 1 % suspension 
based on volume by adding 1 ml of the packed cell to 99 ml of PBS and was 
stored at 4 ºC until used. 
2.10.2.2. Performance of Hemagglutination test (HA) for chicken RBCs 
HA was performed according to OIE manual (1996). Twenty five 
microtiter (µl) of PBS was dispensed into each well of a plastic microtiter plate, 
25 µl of allantoic fluids was placed in the first well. Two-fold dilution was 
done. Then 25 µl of 1 % chicken RBCs was dispensed to each well, the plate 
was tapped gently and then the RBCs were allowed to settle for 40 min at room 
temperature. 
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2.10.3 Hemagglutination inhibition test (HI).  
HA test was made on undiluted influenza antigens. The last well that 
give complete HA was considered one HA unit and the previous well 
considered the 2HA,the 4HA unit were accurately calculated. The virus 
suspension was then diluted to contain 4HA unit per 25µl 
Twenty five microtiter ( µl) of PBS were added to all wells in  plastic 
microtiter plate, 25 µl of tested sera were added into well one, then two-fold 
dilution were performed. The diluted serum samples were mixed with 4HA 
units of virus and incubated at room temperature for 30 min. Then 25 µl of 1% 
chicken RBCs was added to each well and plates were incubated at room 
temperature for 30-45 min. The HI titer was expressed as the reciprocal of the 
highest serum dilution that completely inhibited hemagglutination of 4HA 
units of the virus.  
2.10.4 Agar gel precipitation test (AGPT) for antibody detection 
2.10.4.1. Preparation of agar gel  
 This was applied according to (Beard, 1970). 
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2.10.4.2. Testing and examination of plates. 
 The plugs were carefully removed with a needle. Each peripheral well 
was filled with 25 microtiter of tested sera using microtiter pipette while the 
central well was filled with 25 microtiter of reference antigen.The plates were 
incubated in a humid chamber for ten days at room temperature and were 
examined daily in a dark room through transmitted light for precipitation bands. 
2.10.5 Enzyme- Linked Immunosorbent Assay (ELISA) for the detection 
of antibodies of avian influenza viruses. 
 The AI ELISA Kit was used for detection of antibodies of avian 
influenza viruses type A (BioChek B.V. Crabethstraat 38-C 2801 AN Gouda 
Holland). 
2.10.5.1 Reagents and solutions supplied in the kit  
• Five coated microtiter plates with inactivated AI antigen 
• Negative control serum (1 vial 3 ml) 
• Positive control serum (1 vial 3 ml) 
• Conjugate reagent (Sheep anti chicken 1 vial)  
• Substrate tablets (12 tablets) 
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• Substrate Buffer(1 vial 55 ml) 
• Stop solution (1 vial 55 ml) 
• Sample Diluent (1 vial 250 ml) 
• Washing buffer ( Phosphate Buffer Saline with Tween) 
2.10.5.2 Reagents preparation 
According to manufacture of the kit instructions 
2.10.5.2.1 Preparation of substrate reagent 
Two tablets were added to 11 ml of substrate buffer and allowed to 
dissolve for 3 minutes before being used. 
2.10.5.2.2 Preparation of washing buffer 
The contents of the washing buffer sachet were dissolved in one litre of 
distilled water. 
2.10.5.3 Dilution of samples 
The tested sera were diluted 1:500 by adding 1µl to 500 µl of sample 
diluents and then mixed well by shaking the tubes. 
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2.10.5.4 Test  procedure 
The kit was removed from refrigerator and put at room temperature 
before use. The coated plates were removed from the sealed bags. 
- 100µl of negative control serum were added into wells A1 and B1. 
- 100 µl of positive control serum were added into wells C1 and D1. 
- 100 µl of diluted tested sera were added into the appropriate wells, and then 
plates were covered and incubated at room temperature for 30 minutes. 
After incubation the plates were removed and the contents of wells were 
discarded by flicking them into a sink. All wells were then filled with the 
washing buffer, shaking gently and emptied into a sink. The washing step was 
repeated three times, and then the plates were tapped on absorbent paper. 
2.10.5.4.1 Addition of the conjugate 
Amounts of 100 µl were added to each well. The plate was then shaken 
gently and incubated at room temperature for 30 minutes. After incubation the 
plates were removed and the contents of wells were discarded and then the step 
of washing was repeated. 
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2.10.5.4.2 Addition of substrate 
 Hundred microlitre of the substrate buffer was added to each well. The 
plate was left at room temperature for 15 minutes.  
2.10.5.4.3 Addition of stopping solution 
After 15 minutes 100 µl was added to each well to stop the reaction. 
2.10.5.4.4 Reading of the plate 
 Using the ELISA reader the plate was read at 405 nm and the result was 
printed out. 
2.10.5.4.5 Calculation 
Using sample/positive ratio(S/P ratio) which is calculated as follows: 
      S/P   = 
     
      
2.11 Biological properties of the viruses 
2.11.1 Hemagglutination of avian and mammalian erythrocytes 
2.11.1.1 Preparation of 0.75 % horse RBCs.  
One ml blood was collected into clean sterile tubes containing 2 mg 
sodium citrate, mixed thoroughly to prevent clotting, centrifuged at 200 rpm 
Mean of test sera- Mean of negative control 
 
 Mean of positive control- Mean of negative control 
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for 5 minutes, the supernatant was discarded and cells were resuspended in 
normal saline to make a 0.75 % suspension for agglutination test in plates. 
2.11.2 Determination of the Minimum Lethal Dose50 (MLD50) 
The MLD50 was determined. A total of 30 9-11-day-old embryonated 
eggs were used for inoculation of each isolate.10 fold serial dilutions starting 
from 10-1 throughout to 10-12 were prepared from freshly harvested allantoic 
fluids from the second passage of each virus isolate. Sterile PBS containing 
antibiotics was used as diluent. Five embryonated eggs were inoculated in the 
allantoic cavity with each dilution starting from 10-1.Control eggs were 
inoculated with diluent only. The MLD50 was calculated by the methods of 
Reed and Muench (1938). 
2.11.3 Thermal inactivation  
Freshly harvested allantoic fluids from the fourth egg passage were 
pooled and divided into 10 portions. One was frozen at – 40ºC. The others 
were placed in 50 ml screw capped tubes and submerged in a water bath at 37, 
56 and 70ºC. The contents of the tubes were mixed from time to time before 
each sampling. Samples were collected 5, 10, 15, 30 and 60 minutes after the 
start of the experiment and then rabidly chilled in ice and a portion of each 
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sample was immediately frozen. A portion of each one was used for an 
immediate HA titration. 
2.12 Resistance to disinfectants 
 Three isolates A-11, A-45 and C-45 were used after three passages. 
Infected allantoic fluids (AF) diluted 1:2 in PBS were mixed with disinfectants 
at the ratio of 1:1. The mixtures were held at room temperature as indicated in 
table (3). Disinfectants used were 2% Phenol, 8%Formaline, 70%Ethanol, 1% 
Verkon (s) and 2% Gluteraldahyde. 
2.13  Molecular Technique 
2.13.1 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
Reverse transcription polymerase chain reaction was used for 
examining positive specimens for confirmation. 
2.13.1.1 Viruses 
Five virus isolates of avian influenza, isolated from chickens in 
Khartoum State were propagated in embryonated eggs to obtained fresh 
allantoic fluids. 
2.13.1.2 Primers 
Two primers were used for H5 gene. (IAEA Laboratory, 
Seibersdorf ,Vienna) 
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H5-kha-1: 5⁄ -CCT CCA GAR TAT GCM TAY AAA ATT GTC- 3⁄  
H5-kha-3   : 5 ⁄ - TAC CAA CCG TCT ACC ATK CCY TG - 3 
2.13.1.3 Extraction method of AI RNA from allantoic fluid  
Freshly collected allantoic fluids, containing virus in a concentration of 
not less than 105 MLD50 per 0.1 ml, was used. 
The allantoic fluids was brought out and allowed to thaw. The samples 
were put into 1.5 ml eppendorf tube at the rate of  0.1ml/tube.To each tube, 
1000 µl of Trizol was added; tubes were tightly closed, mixed gently and kept 
for 5 min at room temperature. Then 200µl of chloroforml were added, the 
tubes were mixed gently by inverting it up and down. Tubes were then 
centrifuged at 10 000 rpm for 15 min at 4ºC.After centrifugation, three layers 
were formed of which the colorless upper aqueous layer containing the  RNA. 
The upper layer that contained the RNA was transferred to a new 1.5ml tubes 
and to this volume of  500µl isopropanol was added and mixed by inverting the 
tubes up and down. The tubes were incubated overnight at -20ºC.Tubes were 
then centrifuged at 10 000 rpm for 20 min at 4ºC.After centrifugation, RNA 
precipitated at the side of the tube. Supernatant was removed using a micro 
pipette. To each 1.5 ml tube that contains the RNA pellet,500µl of 75% ethanol 
alcohol were added for washing, gently mixed and centrifuged at 12 000 rpm 
for 10 min at 4ºC.After centrifugation the RNA pellet was carefully dried by 
 57
placing the tubes up side down on a clean paper for 5-10 min at room 
temperature. After drying, 50µl of RNase free water (water for injection) were 
added to every tube, mixed well to dissolve the RNA pellet. The final 
concentration and purity of each RNA sample was measured using 
spectrophotometer and the sample quality was monitored by loading a mixture 
of 2µl RNA, 8µl distilled water and 2µl loading buffer into a 2 % agarose gel 
at 50 volts for half an hour. RNA marker was also loaded. 
2.13.1.4 Determination of the RNA concentration and purity 
  The concentration and purity of the extracted RNA were determined by 
the nano-drop instrument at wavelength of 260/280. The pure preparation of 
RNA has a ratio 1.6 - 1.9. The RNA stock was stored at – 20ºC until used. 
2.13.1.5 Preparation of the Master Mix 
The RT-PCR was carried out in a master mix mixture (25µl) containing 
2.5 µl of 10-times reaction buffer, 2.5 µl dNTPs, 1 µl reverse transcriptase 
(200 units/µl), 0.3 µl RNase inhibitor (40 units/µl), 1.25µl MgCl2, 0.5 µl Taq 
DNA polymerase (9 units/µl), 1 µl of each primer (10 pmol each), and 15 µl of 
water. 
2.13.1.6 Thermocycling 
The PCR condition was done 42ºC for 45 min (reverse 
transcription),95ºC for 3 min,35 cycles of 95ºC for 30 seconds (denaturation), 
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50ºC for 40 seconds (annealing) and 72ºC for 40 seconds (extension), followed 
by 72ºC for 10 min (final extension).  
2.13.1.7 Preparation of agarose gel for electrophoresis 
 2% agarose gel electrophoresis was prepared by dissolving 1gm agarose 
in 45 ml distilled water and 5 ml of 1X TBE buffer. The agar was dissolved by 
heating. The melted agar was Cooled to 60ºC, and then 3µl of ethidium 
bromide was added and mixed well. The melted agarose was poured into the 
gel-casting tray. It was allowed to solidify at room temperature. The gel 
casting tray was placed onto a gel casting base. The tray was placed into the 
electrophoresis chamber with the wells at the cathode side. The buffer chamber 
was filled with 1X TBE at a level that can cover the top of the gel. For sample 
loading, 5µl gel loading buffer was added to each 10µl PCR products.  
5µl of the molecular weight marker (50 bp DNA ladder, promega) were 
mixed with 10µl volume loading buffer then the mixture was loaded into the 
first well of the agarose gel. 15µl of the PCR product was Pipetted to the gel. 
The lid was closed on chamber and attached to the electrodes. The gel was run 
at 50 Volts for 1.4 hours. 
2.13.1.8 Visualization of the gel 
 The gel was visualized under ultra violet transilluminator and 
photographed in a gel documentation system. The size of PCR fragments were 
stimated from their relative distance of migration to the molecular weight 
marker. 
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CHAPTER THREE 
 RESULTS 
 
3.1 Field observations 
 Many poultry farms were visited, where some birds showed respiratory 
signs, but no outbreak of the disease occurred during the study period until 
2006 when the first outbreak of the AI was reported in a poultry farm in 
Khartoum North area. The birds showed typical sings of the disease which 
included depression, ruffled feathers, swelling of the face and head, cyanosis 
of the comb and wattles, diarrhea and respiratory signs including sinusitis and 
nasal discharge. 
3.2  Isolation and identification of the virus 
3.2.1 Isolation of the virus in embryonated eggs 
A total of 5 isolates (2%) were recovered from 250 samples, 3 (3%) 
isolates from 100 cloacal swabs, one (2%) isolate from50 tissue samples (liver, 
lung, trachea) and one (1%) isolate from100 tracheal swabs (Table 2). All the 
isolates were obtained from Khartoum North area. 
The isolates caused death of the embryos within 48 to 96 hr as shown 
by candling. 
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3.2.2 Identification of the virus by Agar gel precipitation test 
3.2.2.1 Reference avian influenza antisera against infected CAM 
Precipitation bands were formed between the reference antisera and all 
positive sample antigen .The bands were slightly faint. Negative CAM showed 
no precipitation band. 
3.2.3 Haemagglutination of chicken and horse RBCs 
All isolates agglutinated Chicken RBCs indicating that they were 
probably influenza viruses. They also agglutinated horse RBCs . 
3.2.4 Hemagglutination inhibition test 
 The test was done using Newcastle disease antisera against the isolates 
to exclude the possibility that hemagglutination was due to Newcastle disease 
virus. After that the allantoic fluids negative for Newcastle disease were tested 
against reference avian influenza antisera 
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Table 2: Isolation of influenza virus in embryonated eggs 
 
samples Number 
examined 
No. positive No. negative 
 
Cloacal swabs 
 
 
Tracheal swabs 
 
 
Tissues 
 
100 
 
 
100 
 
 
50 
 
3 
(3 %) 
 
1 
(1 %) 
 
1 
(2 %) 
 
97 
 
 
99 
 
 
49 
 
Total 
 
250 
 
5 
 
245 
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3.3 Prevalence of AI in Khartoum State as tested by 
3.3.1 Agar gel precipitation test of sera obtained from the farms 
Five hundred and sixteen sera ,254 before the outbreak and 262 after the 
outbreak from different farms in Khartoum State were tested by AGID 
against reference antigen H5N2. 
The results showed that 23 out of 254 sera were positive 19 out of 66 
sera were positive from Khartoum farm 1 and 4 out of 74 were positive from 
Soba farm 2 before the outbreak and all sera from Kalakla,Fitaihab , halfaia 
and Shambat were negative (Table 3). Regarding sera collected after the 
outbreak in 2007, 11 (4.2%) out of 262 sera were positive from Fakihashim 
farm and all sera from other farms were negative (Table 4). 
3.3.2 Enzyme –linked immunsorbant assay (ELISA) 
3.3.2.1 Detection of antibodies in tested sera 
The 254 sera collected during 2004-2005 and 262 collected in 2007 
were tested for presence of avian influenza antibodies using the ELISA test for 
type A. Positive and negative sera were determined using the S/P ratio.  
Sera reading 0.500 or greater were considered as positive while sera 
reading 0.499 or less were considered as negative.   
The results showed that 94 (37%) were positive from 2004-2005, 2 out 
of 25 were positive from Fitaihab farm, 13 out of 40 were positive from 
Halfaia farm, 3 out of 24 were positive from Shambat farm, 58 out of 66 were 
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positive from Khartoum farm 1 and 18 out of 74 were positive from Soba farm             
2 (Table5).The result also showed that 41(16%) were positive from sera 
collected in 2007 after the outbreak (Table 6). 
3.3.3 Haemagglutination inhibition test 
 Positive sera obtained by ELISA were tested against two reference 
antisera H5N3 and H7N1.Atotal of 94 sera collected before outbreak and 
positive to ELISA were tested by HI test, the results obtained was that 28 sera 
were positive, 17(60.7%) for H5N3 and 11(39.3%) for H7N1. The results for 
sera collected after the outbreak showed that only 6(14.6%) sera out of 41 
positive to ELISA were found positive to  H5N3 (Table 7).  
3.4 Pathogenicity test of isolates 
3.4.1 Growth on cell culture and plaque production 
The isolates produced large plaques with high efficiency in CEF. They 
were also plaqued in CKC, with more varied shapes and efficiency was slightly 
reduced. 
Results in CKC were better. Five isolates of avian influenza viruses 
were tested for the ability of these isolates to form plaques on cells cultures. 
One isolate readily produce countable plaques (Figure 5).Thus, CEF and CKC 
appear suitable for plaque assaying of AI viruses. 
  The isolates were found to be Cytopathic for CKC and CEF. The CPE 
was first observed after 24 hours post infection, it was similar for all inoculated 
 64
isolates. Figure (1) showed normal tissue culture of CEF, figure (3) showed 
normal tissue culture of CKC and figures (2 and 4) showed the CPE of the 
isolates.Clear CPE was observed for all isolates tested. 
3.5 Biological properties of the isolates 
3.5.1 The Minimum Lethal Dose (MLD50) 
Five viruses were isolated during the study from 250 samples. Titration 
of the viruses in ten-day-old chick embryos was done. The chick-embryo 50% 
leathality rate (MLD50) for the five isolates were calculated by Reed and 
Muench method (1938) these were shown in (Table 8). 
3.5.2 Thermal inactivation 
The results of this study confirmed that avian influenza virus is readily 
inactivated by heat. Inactivation experiments were conducted as previously 
described. Inactivation levels were determined by comparing virus titers. 
(Tables 9, 10) 
3.6  Resistance to disinfectants 
The three isolates A-11, A-45 and C-45 proved to be resistant to 2% 
phenol at one min, but were completely inactivated at 30min. 2% 
Gluteraldahyde was also found to be ineffective at one min and 10min. 
8%Formalin caused an almost complete inactivation of the viruses at all 
exposure times.  1%Virkon(s) and 70% ethanol reduced the virus titer in 30 min 
(Table 11).  
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3.7  RT-PCR 
3.7.1 Purity and concentration of RNA extracts 
 For extraction of viral RNA from allantoic fluid, the Trizol method was 
used (Ming, 2001),when the viruses were exposed to 1 ml Trizol for 5 minutes 
at room temperature they gave purity range from 0.81-1.6 and concentration 
range from 29.4-89.1 ng/µl (Table 12).  
3.7.2 Confirmation of the virus isolates by RT-PCR  
 Two primers were used to detect, identify and confirm the isolates. Five  
isolates were  tested by RT-PCR. All 5 isolates collected from one farm in 
Khartoum north area in 2006 were found positive after RT-PCR amplification 
using H5 gene primers of AI virus (Figure 6). 
  All of them gave PCR fragments of about 300 base pairs (bp) on 2% 
agarose gel when estimated from their relative distance of migration of the 
molecular weight marker (Figure 7). The results were confirmatory for the 
virus isolation and serological sub typing. 
The isolates were found to be AI virus type A subtype H5 when 
compared to the positive control. 
. 
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Table (3): Results of AGID for sera collected before AI outbreak in 
Khartoum State 2006-2007 
 
AGID  
Locality POSITIVE NEGATIVE 
 
Total 
Kalakla - 25 25 
 
Fitaihab - 
 
25 25 
 
Halfaia - 40 40 
 
 
Shambat - 24 24 
Farm1 K 19 47 66 
Farm2 S 4 
 
70 74 
 
Total 23 
(9%) 
 
231 254 
 
K  Khartom 
S  Soba 
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Table (4): Results of AGID for sera collected after AI outbreak in 
Khartoum State 2006-2007 
 
AGID  
Locality POSITIVE NEGATIVE 
 
Total 
 
Halfaia 
 
- 
 
35 
 
35 
 
Koko 
 
- 
 
25 
 
25 
 
Shambat 
 
- 
 
13 
 
13 
 
Fakihashim 
 
11 
 
44 
 
55 
 
Drwshab 
 
- 
 
35 
 
35 
 
Fitaihab 
 
- 
 
16 
 
16 
 
Samrab 
 
- 
 
38 
 
38 
 
Tebna 
 
- 
 
45 
 
45 
 
Total 
 
11 
(4.2%) 
 
251 
 
262 
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Table (5): Detection of antibodies using ELISA test for sera collected 
before AI outbreak in Khartoum State 2006-2007 
 
ELISA  
Locality POSITIVE NEGATIVE 
 
Total 
 
Kalakla 
 
- 
 
25 
 
25 
 
Fitaihab 
 
2 
 
23 
 
25 
 
Halfaia 
 
13 
 
27 
 
40 
 
Shambat 
 
3 
 
21 
 
24 
 
Farm 1K 
 
 
58 
 
8 
 
66 
 
Farm 2S 
 
18 
 
56 
 
74 
 
Total 
 
94 
(37%) 
 
160 
 
254 
 
K  Khartom 
S  Soba 
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Table (6): Detection of antibodies using ELISA test for sera collected after 
AI outbreak in Khartoum State   
 
ELISA  
Locality POSITIVE NEGATIVE 
 
Total 
Halfaia 6 29 35 
Koko 2 23 25 
Shambat 2 11 13 
Fakihashim 19 36 55 
Drwshab 4 31 35 
Fitaihab 2 14 16 
Samrab - 38 38 
Tebna 6 39 45 
 
Total 
41 
(15%) 
221 262 
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Table 7: Comparison of positive results of sera tested with ELISA, AGID 
and HI test 
 
HI outbreak Total of 
samples 
ELISA AGID 
positive negative 
subtype 
 
 
 
Before 
 
 
 
254 
 
 
 
94 
 
 
 
23 
 
 
 
28 
 
 
 
66 
 
  H5N3 
17(60.7%)  
   
   H7N1 
11(39.3%)  
 
 
 
after 
 
 
262 
 
 
41 
 
 
11 
 
 
6 
 
 
35 
 
  H5N3 
6 (100%) 
  H7N1 
0 
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Table (8): Determination of the Minimum Lethal Dose (MLD50) of AI 
iso;ates 
 
Virus MLD50 
 
A-1 
 
 
A-11 
 
 
A-45 
 
 
C-1 
 
 
C-45 
 
 
10 5.6 
 
 
10 7.4 
 
 
10 6.6 
 
 
10 5.5 
 
 
10 5.6 
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Table 9:   Inactivation of the isolates by heat  
 
  Time (min) 
Isolate Temperature 0 5 10 15 30 60 
37 0C + + + + + + 
56 0C + + + + - - 
 
 
 
A-11 
70 0C + - - - - - 
37 0C + + + + + + 
56 0C + + + + - - 
 
 
A-45 
70 0C + - - - - - 
37 0C + + + + + + 
56 0C + + + + - - 
 
 
 
C-45 
70 0C + - - - - - 
 
 
+ Positive for HA 
- Negative for HA 
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Table (10): Effect of temperature on the stability of haemagglutinin of three influenza virus isolates 
 
 
Temperatures  
Titer 
37ºC 56ºC 70ºC 
Time 
 
 
 
Isolate 5 10 15 20 30 60 5 10 15 20 30 60 5 10 15 20 30 60
 
A-11 
 
160 
 
160 
 
160
 
160
 
160
 
160
 
80 
 
80 
 
80 
 
80 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
A-45 
 
160 
 
160 
 
160
 
160
 
160
 
160
 
80 
 
80 
 
80 
 
80 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
C-45 
 
160 
 
160 
 
160
 
160
 
160
 
160
 
80 
 
80 
 
80 
 
80 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
 
0 
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Table 11: Inactivation of the virus by disinfectants at room temperature 
 
A-11 A-45 C-45  
1 10 30 60 1 10 30 60 1 10 30 60 
Phenol + 
 
+ - - + 
 
+ - - + 
 
+ - - 
Formaline - 
 
- - - - 
 
- - - - 
 
- - - 
Virkon(s) + 
 
+ + - + 
 
+ + - + 
 
+ + - 
Gluteraldahyde + 
 
+ - - + 
 
+ - - + 
 
+ - - 
Ethanol + 
 
+ + - + 
 
+ + - + 
 
+ + - 
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Table 12: Concentration and purity of the isolates and positive control 
virus 
 
Isolate Concentration Purity 
A-1 
 
29.4 1.6 
A-11 
 
63 1.4 
A-45 
 
89.1 0.81 
C-1 
 
43 0.93 
C-45 
 
67 1.6 
Positive control 
 
61 1.13 
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Fig. (1): Normal tissue culture of CEF 
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Fig. (2): CPE in CEF cells infected with the A-11 isolate 
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Fig. (3): Normal tissue culture of CKC 
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Fig. (4): CPE in CKC cells infected with the AI  isolates 
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Fig(5): Plaque caused by A-45 isolate  on CKC  
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Fig. (6): Polymerase chain reaction amplification of isolated AI viruses 
 
 
300 bp
 
     1    2   3   4   5   6   7 
 
 
Lane 1- 5 field isolates, Lane 6 positive control and lane 7 negative control 
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Fig(7): PCR amplification pattern of isolates using H5 primers in 2 % 
agarose gel 
 
 
 
  1 2   3   4      5        6         7  8                                         
     
Lane 1 Negative control 
 2 Positive control 
 3-7 field isolates 
 8 Molecular weight marker 
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CHAPTER FOUR 
DISCUSSION 
Avian influenza is one of the emerging diseases of zoonotic nature that 
threaten the livelihood of millions of small scale farmers. It is caused by 
influenza A viruses, which can affect a variety of domestic and wild bird 
species. Infection can range from asymptomatic to severe, depending on the 
virulence of the virus and the susceptibility of the avian host. It is defined as a 
notifiable disease by the OIE.A major concern was the possibility that the virus 
might spread to large populations. It became a disease of great importance for 
animal and human health. The study was carried out to determine the presence 
of antibodies to influenza virus, in addition to isolate, identify, characterize and 
determine pathogenicity of isolates.Also to the study of stability of the isolates 
to different temperatures and various disinfectants. 
The current avian influenza outbreaks which started in Asia in 2004 are 
caused by a virus of the H5 subtype which was further characterized as of the 
N1 subtype that was responsible for some human deaths. There is a current 
worldwide focus on avian influenza and due to the implication of disease 
spread to humans, the disease is considered a priority. The rapid spread of AI 
between countries and into new species intensified the risk of a pandemic that 
may affect both humans and animals. This emphasizes the need of a global 
effort to provide early, rapid detection of the virus.  
 84
Few surveys have been carried out about the disease in poultry in Sudan 
to determine the prevalence of the disease. AI in the Sudan was reported for 
the first time in 1923 (Report of the Sudan Veterinary Service, 1923).However, 
serious attempts to study the disease in poultry were not made until 1985 when 
Alamin and Khier examined sera from large animals in Kassala region, and 
found that many animals from all species were positive to the AGID. Alamin 
(2000) was able to isolate the AI virus type A for the first time in the Sudan 
which probably belonged to the mild type as it was not fully characterized.  
During this study an outbreak of AI occurred in 2006 in poultry farms in 
Khartoum State in winter, which agreed with Elamin (2000) who reported that 
outbreaks of the disease occurred in Khartoum in 1998 in winter. 
During the present work three serological tests for antibody detection, 
ELISA, AGID and HI were used, isolation of AI virus was attempted from 
tissues cloacal and tracheal swabs. 
A total of 250 samples consisting of tissues, cloacal and tracheal swabs 
were examined for the isolation of the virus. The virus isolation rate in the 
poultry farms after the outbreak from cloacal swabs were higher than those 
detected in tissue, and the rate of virus isolation was 20% from the tissue and 
80% from cloacal swabs. 
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The isolates were identified as influenza virus type A by AGID and 
were sub typed using H5N3 and H7N1 antisera in the HI test. The five isolates 
were inhibited by AI antiserum to H5N3. 
A total of 516 sera collected from different farms in Khartoum State 
before and after outbreak were examined by serological tests. 
The results of tested sera using AGID showed that 34 were positive, 
23(9%) before the outbreak and 11(4.2%) after the outbreak (Table3, 4). 
The results of tested sera during the present work using the AGID 
showed lower antibody prevalence compared to those reported earlier by 
workers who used the same test. Although 9% and 4.2 % of the birds were 
found positive before and after the outbreak, Elamin (2000) reported that 18% 
of 100 birds were positive. The lower rate of positive result could be attributed 
to the fact that the samples were collected from apparently healthy poultry with 
no report of outbreaks. The positive rates dropped from 9% before the outbreak 
to 4.2 % after it and this might be due to the fact that all the exposed birds were 
killed after occurrence of the disease outbreaks.    
A total of 516 sera were tested by ELISA among which 135 (26.2%) 
were positive. Elamin (2000) examined 120 sera from birds and found that 
28.4% were positive. Wegdan et al., (2007) examined 1054 sera and found that 
911(86.4%) were positive.  
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For subtyping the antibodies detected by ELISA and AGID using H5N3 
and H7N1 antigens the results revealed that among sera collected during 2004-
2005 17(60.7%) out of 94 were positive to H5N3 antigen and 11(39.3%) were 
positive to H7N1 antigen. Of a total of 41 serum samples collected from 
poultry in 2006 the results showed that only 6(14.6) were positive to H5N3 
antigen and there is no antibody detected against H7N1. 
The difficulties in control of AI in developed as, well as in developing 
countries is well documented. Biosecurity is regarded as the most important 
tool in controlling the disease. Economic losses to the poultry industry, food 
security in developing countries, the great threat to the human health and the 
possibility of the risk of the emergence of  a new pandemic due to a new strain 
which may arise from the animal reservoir, because of all these the biological, 
biochemical and physiochemical characteristics of AI were studied. It is well 
known that the AIV is rather fragile in higher temperature; this was confirmed 
during this study as the virus was reported to be very sensitive to 700C for one 
minute.  
Study on the stability of isolates to some various physical and chemical 
agents indicated that either 8% Formalin or 2%phenol were the most effective 
disinfectants for inactivation of influenza virus based on HA activity results. 
The use of Formalin would likely be less expensive, but has toxicity; phenol 
would be more suitable for sensitive environments and materials. Results also 
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indicated that the isolates were resistant to 1% Virkon(s), 2% Gluteraldahyde 
and 70% Ethanol for 5 min at room temperature. 
Other physical properties were also investigated. The study indicated 
that the virus was very sensitive to 700C for 1 min, but it was resistant to 37 0C 
and 56 0C for 5 min, but they lost their effectivity at 30 min at 370C and 560C.  
Attempts were made to develop a plaque test in Chick Embryo 
Fibroblast (CEF), Chick Kidney (CK) cell cultures. The data suggested that the 
chick embryo provides a very good isolation system. The isolates produced 
clear plaques of small size on primary CEF and CKC within 48 hr post 
inoculation without addition of trypsin. These results confirmed the virulence 
of the isolates according to OIE report that the virulent strains produce plaques 
in cell culture (OIE, 1996). 
Methods effective for early, rapid detection and confirmation of 
diseases are recommended and performed according to the OIE guidelines. 
 Conventional microbiological assays should always be maintained to 
validate and guide further developments with the novel diagnostic techniques. 
In this contest, nucleic acid-based technologies have contributed considerably 
to the field of diagnosis. The PCR is considered as a major advance in the 
technology of nucleic acid detection, whereas real-time PCR (RRT-PCR) is a 
widely used technique which facilitates early, rapid detection of the viruses. It 
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involves the use of fluorescent probes to moniter the identity and amount of 
product at the end of each cycle and hence it is a quantitative PCR. 
Conventional methods were used for virus isolation and were later 
confirmed by novel methods which involve the use of nucleic acid-base 
techniques, mainly RT-PCR. The virus is usually first isolated from 
pathological materials in embryonated chicken eggs, the methods takes about 
4-7 days. This is followed by subtype identification using a battery of specific 
antibodies raised against the different hemagglutinin H (H1-H15) and 
neuraminidase N (N1-N9) proteins. 
In spite of lack of adequate facilities for safety measures to handle the 
virus and the fact that these tests (HA, NA, HI, NI) have to be performed in 
specialized laboratories, but it was possible to perform the isolation steps 
successfully and with minimum but careful safety and biosecurity measures. 
The results obtained by the HA and HI tests which are considered as type –
specific tests, are very good and five AI type A could be detected right after 
the first passage of the virus with relatively suitable HA and HI titers. No NA 
or NI was performed due to lack of materials. Mortality of inoculated chick-
embryos took place 48 hours post inoculation. 
The AGID was performed for group-specific identification of type A 
virus. It was a rapid, sensitive and specific test through which it was possible 
to detect 5 type A viruses among the field specimens tested. 
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For pathogenicity determination, the isolate is usually injected into 6-8 
week-old susceptible chickens: according to OIE, mortality rate exceeding 75 
% within 10 days indicated a highly pathogenic virus; this could not be 
performed due to lack of enough safety facilities and fear of causing hazards to 
both human and birds in the laboratory. Instead, the pathogenicity of the virus 
isolates was determined by propagation of the virus in cell culture and its 
plaquing in semi-solid media. All five isolates produce clear cytopathic effect 
(CPE) clear small plaques readily within 48 hours post inoculation. Plaque 
production by AIV indicates that the viruses are of the highly pathogenic type 
in nature. It was stated that highly pathogenic AIV strains produce plaques in 
cell culture while mild ones do not (OIE, 2003). Moreover, both CEF and CKC 
proved to be very good hosts for propagation of the AI virus.  
The AI outbreak in Sudan in 2006 caused by type A avian influenza 
virus of H5N1 subtype demonstrated the need to reduce the time required for 
disease diagnosis and rapid detection of the virus. RT-PCR technique was used 
for characterization of the isolates and confirmation of the results that were 
obtained by conventional virus isolation (VI).Trizol method was used for 
extraction of the RNA from infected allantoic fluids (Ming et al.,  2001) which 
was found to increase the sensitivity and quality of the RT-PCR assays, the 
results was similar to those obtained by Starick (2003). The results indicated 
that the five isolates were avian influenza type A subtype H5 when two 
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primers for H5 gene were used. The RT-PCR is found to take less time to 
characterize the virus compared to the conventional methods. The results of the 
RT-PCR compared with virus isolation  and serological tests, confirmed that 
all isolates were found to be H5, therefore the sensitivity for the detection of 
AIV by RT-PCR and by conventional methods were found to be comparable, 
but the issue is rapid diagnosis achieved by using RT-PCR. 
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Conclusions and recommendations 
 
The present work has confirmed the presence of AI disease in Khartoum 
State. It can be concluded that  
1. The prevalence of AI disease was confirmed and that can be seen by 
isolation of AI from the outbreak that occurred in Khartoum State by 
serological surveillance during this study. 
2. Extraction of AI antigen from 5 isolates in allantoic fluid by Trizol 
method is a reliable method. 
3. The RT-PCR is a useful test for detection and confirmation of the the AI. 
4. Chick Embryo Fibroblast (CEF) and Chick Kidney Cell (CKC) can be 
employed in isolation and plaque production of AIV. 
5. AI virus was inactivated at all exposure times by 8 % formaline,and by 
heat at 70 0C for 5 min and 30 min at 56 0C.  
Recommendations 
1. Further serological surveillance to cover all States of Sudan has to be 
conducted to clarify the situation of the disease in the country. 
2.  Because of disease situation, AI vaccine is recommended to be 
introduced for control of the disease. 
3. Rapid methods for diagnosis of AI are to be established and 
implemented, mainly nucleic acid base techniques. 
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APPENDICES 
Appendix I 
Deionized distilled water: 
Water was distilled to get rid of salts and passed through deionizer to 
get rid of ions. Deionized distilled water (DDW) was used in preparation of 
solutions besides washing of equipment. 
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Appendix II 
HA, HI and tissue culture reagents and solutions  
1. Normal saline  
This was prepared by dissolving 0.85 gram of sodium chloride in 100 
ml distilled water.  
2.  Phosphate Buffer Saline (PBS)  
This was prepared as follow.  (1 liter) 
Solution A    Na CL                                   8.0 gm  
                                        KCL                                     0.20 gm 
                                       Na2HOP4.2H2O                    1.44 gm 
                                        KHPO4                                  0.2 gm 
                                       Distilled water                     800.0 ml 
Solution B   Ca CL2        0.1 gm 
    Distilled water  100.0 ml 
    
Solution C                   Mg CL2.6H2O                           0.10 g 
                                     Distilled water                        100.0 ml 
Solution A, B and C were autoclaved separately and left to cool. Then 
solution A was added to solution B then C and the mixture was made up to 1 
liter with distilled water (Patrick et al , 2003).  
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3.  Alsever's Solution  
       This was prepared as follow:      
Dextrose                                                20.5 g  
Na CL                                                     4.2 g  
Sodium Citrate                                       8.0 g  
Citric acid                                                0.55 g  
  The mixture was completed to one liter with distilled water and 
autoclaved at 115 ºC for 10 minutes. 
4. Phosphate diluent (PD) 
 NaCl      16.0 gm 
 K Cl      0.4 gm 
 Na2 HPO4     2.3 gm 
 KH2 PO4     0.4 gm 
DDW  complete to 2000 ml 
The PD is used for the preparation of cell disperising solutions such as 
0.25% trypsin. 
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Appendix III 
Antibiotics 
1.  Stock Solution   
1 gram streptomycin vial was dissolved in 5 ml distilled water.           10 
I.U Penzyle Penicillin 1 vial was dissolved in 10 ml distilled water.             2 
ml Gentamycin 1 vial was dissolved in 12 ml distilled water. Those were then 
distributed each in sterile vials in amounts of 2 ml in each vial and stored at -
40ºC until used. 
2.  Working Solution  
For suspension of material for chick inoculation.   
Penicillin          10000 I.U/ ml                               1 ml  
Streptomycin                                                         1 ml  
Gentamycin                                                           1 ml  
Fungizon                                                                1 ml 
Complete to 50 ml by PBS                                   46 ml  
Total                                                                      5o ml 
Stored at - 40 ºC until used. 
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Appendix IV 
Tissue culture media and additives 
1.  Preparation of one litre of Growth Minimum Essential Medium 
(GMEM) X 5 Concentration (stock). 
0.5 gram of growth minimum essential medium was dissolved in one 
litre of DDW and sterilized by filtration. It was then dispensed in 0.5 litre 
amount and frozen at -20C0.  
2.  Preparation of GMEM X1 Conc (one litre) 
 GMEM X5     200 ml 
 Lactalbumen hydrolysate 5%  025ml 
 Yeast extracts 1%    025ml 
Antibiotics (penicillin, streptomycin, 004ml 
gentamycin, mycoststin ) 
 NaHCO3 7.5%    008ml    
 DDW  complete to    1000ml    
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3.  Preparation of GMEM outgrowth Medium (100ml) 
 GMEM X1      85ml  
 Tryptose phosphate broth 5%  05ml 
 Calf serum     10ml 
 Total      100ml 
4.  Preparation of 2- fold GMEM (100ml) 
 GMEM X5 conc    40ml 
 Lactalbumin hydrolysate    05ml 
 Yeast extract     05ml 
NaHCO3 7.5%    00.8ml 
Antibiotics     00.6ml 
DDw      48.6ml   
Total      100ml 
Bovine serum albumin   01ml  
5.  Preparation of first overlay medium (100ml) 
  I) 2- fold GMEM   90ml 
     TPB     05ml 
      Calf serum    05ml 
  II) 1.4 % agar in DDW 
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Prepared by dissolving 1.4 grams of purified agar in 100 ml of DDW 
and boiling the mixture for 1 hour,  then transferring it to a water bath at 430C. 
Equal volume of I and II were mixed and used as a first overlay 
medium. 
6.  Preparation of a second overlay medium 
This contained first overlay medium, 0.2 % bovine serum albumen (1% 
of a 2.5% stock solution). 
7.  Tissue culture additives 
7.1 Preparation of Tryptose Phosphate Broth (TPB) 5% solution 
   (One litre) 
 Tryptose phosphate powder   29.5g 
 DDW       1000ml 
 Sterilized by autoclaving for 30 minutes at 15 Ib pressure. 
7.2 Preparation of 7.5% NaHCO3 solution (100ml) 
 NaHCO3 powder     7.5g  
 DDW       100ml  
 Sterilized by autoclaving for 30 minutes at 15 Ib pressure . 
7.3 Preparation of 5% lactalbumen hydrolysate solution (500ml) 
 Lactalbumen hydrolysate powder  25g 
 DDW       500ml 
  Sterilized by autoclaving 
 130
7.4 Preparation of 1% Yeast extract solution (500ml) 
 Yeast extract powder    5g 
 DDW       500ml 
8.  Cell-Dispersing solutions. 
8.1 Preparation of 2.5% Trypsin (0.5 litre)  
 Trypsin powder     37.5 gm 
 PD solution      500.0 ml 
 The solution was filtered through a filter paper and finally sterilized by 
filteration. 
 
8.2 Preparation of 0.25 trypsin solution 
 2.5% trypsin solution    10.0 ml 
 PD solution      90.0 ml 
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Appendix V 
PCR reagent 
1. Ethidium bromide 
Ethidium bromide is a fluorescent dye able to detect DNA in agar gel 
electrophoresis. It was prepared in a concentration of 0.5 µg/ml in TBE buffer 
and stored in a confined light tight container brown bottle at room temperature. 
The ethidium bromide powder is powerful mutagen and toxic dye that gloves 
ought to be wear during working and dye or powder ought to be 
decontaminated after use. 
2. PCR marker (DNA ladder): 
50 bp consisted to 16 DNA fragments with size of 50, 100, 150, 200, 
250, 300, 350, 400, 450, 500, 550, 600, 650,700,750, and 800 bp. The marker 
was stored at -20oC till used. 
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3. Preparation of 10X Tris Borate EDETA (TBE) one litre 
Tris Base       108 g   
Boric acid       55 g    
EDETA       9.3 g 
Distilled water to     1000 ml 
The solution was sterilized by autoclaving and stored at room temperature. The 
buffer was diluted then and used as 1x. 
4. Working solution (1x) 
 TBE stock solution    5 ml     
Sterile distilled water   95 ml     
Mixed well by agitation and the buffer was kept  at room temperature 
until used as running buffer during electrophoresis run and as a solvent for agar 
gel electrophoresis powder. 
 
 
 
